Skip to content
Draft: numbers and prose are under review
Contents
Weights, Design, and Estimands

Part I Chapter 3

Point Estimates and Design-Based Uncertainty

Nearly half of adults have hypertension. How many know it, treat it, and control it, and how sure can we be?

DataNHANES 2021–2023 · NHIS · BRFSS · Taylor linearization

A standard error of what?

The software printed a standard error. Is it the standard error of anything? You have a public-use health file open and a difference between two weighted shares, and one call gives it a p-value of 0.0220.022EstimandTwo-sided naive p-value for chg_control_menVarianceNone reportedSourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquet; NHANES 2017-March 2020 pre-pandemic (P_ files); nhanes_analysis.parquet + nhanes_full_1999_2023.parquet (BPQ040A/BPQ050A) while another gives 0.0810.081EstimandTwo-sided full-design p-value for chg_control_menVarianceNone reportedSourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquet; NHANES 2017-March 2020 pre-pandemic (P_ files); nhanes_analysis.parquet + nhanes_full_1999_2023.parquet (BPQ040A/BPQ050A). One of them goes in the paper, and nothing in the output says which. The two calls agree on the estimate. They disagree about a single input: a statement about the repetition that makes an estimate vary, which one call was given and the other was not. This chapter is about that input, what it costs to leave it out, and how to tell when leaving it out changes a conclusion.

The difference in question is a change in blood pressure control among men. Nearly half of U.S. adults have high blood pressure: in August 2021–August 2023, 47.7% (95% CI 45.4%–49.9%)47.7% percentEstimandCrude prevalence of hypertension among U.S. civilian noninstitutionalized adults 18+ (pregnant women excluded), Aug 2021-Aug 202395% CI45.4%–49.9% (t, df = 15)n6,084WeightWTMEC2YRVarianceTaylor linearization (design-based)SourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquetExternal benchmarkexternal benchmark: NCHS Data Brief 511 reports 47.7% (95% CI 45.4-49.9), SE 1.1, n = 6,084 met the definition the National Center for Health Statistics (NCHS) uses, a reading of 130/80 mm Hg or higher in the examination room or current use of prescribed blood-pressure medication. Hypertension is treatable in a specific sequence, and public health counts the steps as a cascade. Among adults with hypertension, 59.2%59.2% percentEstimandShare told by a health professional they have hypertension, among adults 18+ with hypertension (SBP >= 130 or DBP >= 80 mm Hg, or taking BP medication), Aug 2021-Aug 202395% CI56.5%–61.9% (t, df = 15)n3,240WeightWTMEC2YRVarianceTaylor linearization (design-based)SourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquetExternal benchmarkexternal benchmark: NCHS Data Brief 511 reports 59.2% (95% CI 56.4-61.9), SE 1.3, n = 3,240 had been told so by a health professional, 51.2%51.2% percentEstimandShare taking prescribed BP medication, among adults 18+ with hypertension (SBP >= 130 or DBP >= 80 mm Hg, or taking BP medication), Aug 2021-Aug 202395% CI48.7%–53.7% (t, df = 15)n3,238WeightWTMEC2YRVarianceTaylor linearization (design-based)SourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquetExternal benchmarkexternal benchmark: NCHS Data Brief 511 reports 51.2% (95% CI 48.6-53.7), SE 1.2, n = 3,238 were taking medication for it, and 20.7%20.7% percentEstimandShare with SBP < 130 and DBP < 80 mm Hg, among adults 18+ with hypertension (SBP >= 130 or DBP >= 80 mm Hg, or taking BP medication), Aug 2021-Aug 202395% CI18.8%–22.7% (t, df = 15)n3,242WeightWTMEC2YRVarianceTaylor linearization (design-based)SourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquetExternal benchmarkexternal benchmark: NCHS Data Brief 511 reports 20.7% (95% CI 18.8-22.8), SE 0.9, n = 3,242 had their blood pressure under control. The shares come from the National Health and Nutrition Examination Survey (NHANES), which measures blood pressure in a mobile examination center rather than asking about it, and NCHS published them in Data Brief 511 (Fryar et al. 2024). The brief also answers the question clinicians asked as the pandemic receded: did control get worse? Between 2017–March 2020 and August 2021–August 2023, NCHS reported no detectable change in awareness, treatment, or control.

20.7%20.7% percentEstimandShare with SBP < 130 and DBP < 80 mm Hg, among adults 18+ with hypertension (SBP >= 130 or DBP >= 80 mm Hg, or taking BP medication), Aug 2021-Aug 202395% CI18.8%–22.7% (t, df = 15)n3,242WeightWTMEC2YRVarianceTaylor linearization (design-based)SourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquetExternal benchmarkexternal benchmark: NCHS Data Brief 511 reports 20.7% (95% CI 18.8-22.8), SE 0.9, n = 3,242

of adults with hypertension had it under control, August 2021–August 2023

95% CI 18.8%–22.7%

That conclusion is easy to overturn by accident. Among men with hypertension, the estimated change in control is −3.0 (95% CI −6.4 to 0.4)−3.0 percentage pointsEstimandChange in control (adults with hypertension; Men), Aug 2021-Aug 2023 minus 2017-March 2020, percentage points95% CI−6.4 to 0.4 (t, df = 38)n3,846WeightWTMEC2YR (2021-2023) / WTMECPRP (2017-March 2020)VarianceTaylor linearization (design-based)SourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquet; NHANES 2017-March 2020 pre-pandemic (P_ files); nhanes_analysis.parquet + nhanes_full_1999_2023.parquet (BPQ040A/BPQ050A)Notenaive p = 0.022; design p = 0.081 (Satterthwaite df 38.3) percentage points. An analyst who computes weighted shares with a group-by and attaches the textbook standard error reports a significant decline, p = 0.0220.022EstimandTwo-sided naive p-value for chg_control_menVarianceNone reportedSourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquet; NHANES 2017-March 2020 pre-pandemic (P_ files); nhanes_analysis.parquet + nhanes_full_1999_2023.parquet (BPQ040A/BPQ050A). An analyst who declares NHANES's sampling design reports p = 0.0810.081EstimandTwo-sided full-design p-value for chg_control_menVarianceNone reportedSourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquet; NHANES 2017-March 2020 pre-pandemic (P_ files); nhanes_analysis.parquet + nhanes_full_1999_2023.parquet (BPQ040A/BPQ050A). Same files, same weights, same point estimate. Men's control is also one of 24 period comparisons, four stages of the cascade in six groups of adults, so one small p-value among them deserves suspicion before the design is even declared.

The cascade, counted the way NCHS counts it

The target population is U.S. civilian noninstitutionalized adults 18 and older, excluding pregnant women, in August 2021–August 2023. Blood pressure is the average of up to three oscillometric readings taken in the mobile examination center (MEC). Hypertension is a systolic pressure of 130 mm Hg or more, a diastolic pressure of 80 or more, or a yes to "Are you now taking any medication prescribed by a doctor for your high blood pressure?" Awareness is a yes to ever having been told of hypertension by a doctor or other health professional. Treatment is the medication question. Control is systolic below 130 and diastolic below 80. Awareness, treatment, and control are shares of adults with hypertension, not of all adults and not of those at the previous stage. The analytic sample is 6,0846,084EstimandExamined adults 18+ in the analytic sample (not pregnant, at least one valid BP reading)n6,084VarianceNone reportedSourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquetExternal benchmarkNCHS Data Brief 511: n = 6,084 examined adults, 3,2423,242EstimandExamined adults with hypertension (control denominator)VarianceNone reportedSourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquetExternal benchmarkNCHS Data Brief 511: n = 3,242 of them with hypertension, the brief's counts exactly.

The hypertension cascade, August 2021–August 2023

Adults 18+; awareness, treatment and control are shares of adults with hypertension; 95% intervals

  • Design-based
  • External benchmark
THIS CHAPTER (TAYLOR, DF 15)Prevalence (all adults): 47.7% (95% CI 45.4%–49.9%), n = 6,084Prevalence (all adults)NCHS DATA BRIEF 511 (PUBLISHED)Prevalence (all adults): 47.7% (95% CI 45.4%–49.9%), n = 6,084Prevalence (all adults)THIS CHAPTER (TAYLOR, DF 15)Awareness (with hypertension): 59.2% (95% CI 56.5%–61.9%), n = 3,240Awareness (with hypertension)NCHS DATA BRIEF 511 (PUBLISHED)Awareness (with hypertension): 59.2% (95% CI 56.4%–61.9%), n = 3,240Awareness (with hypertension)THIS CHAPTER (TAYLOR, DF 15)Treatment (with hypertension): 51.2% (95% CI 48.7%–53.7%), n = 3,238Treatment (with hypertension)NCHS DATA BRIEF 511 (PUBLISHED)Treatment (with hypertension): 51.2% (95% CI 48.6%–53.7%), n = 3,238Treatment (with hypertension)THIS CHAPTER (TAYLOR, DF 15)Control (with hypertension): 20.7% (95% CI 18.8%–22.7%), n = 3,242Control (with hypertension)NCHS DATA BRIEF 511 (PUBLISHED)Control (with hypertension): 20.7% (95% CI 18.8%–22.8%), n = 3,242Control (with hypertension)PercentTHIS CHAPTER (TAYLOR, DF 15)Prevalence (all adults): 47.7% (95% CI 45.4%–49.9%), n = 6,084Prevalence (all adults)NCHS DATA BRIEF 511 (PUBLISHED)Prevalence (all adults): 47.7% (95% CI 45.4%–49.9%), n = 6,084Prevalence (all adults)THIS CHAPTER (TAYLOR, DF 15)Awareness (with hypertension): 59.2% (95% CI 56.5%–61.9%), n = 3,240Awareness (with hypertension)NCHS DATA BRIEF 511 (PUBLISHED)Awareness (with hypertension): 59.2% (95% CI 56.4%–61.9%), n = 3,240Awareness (with hypertension)THIS CHAPTER (TAYLOR, DF 15)Treatment (with hypertension): 51.2% (95% CI 48.7%–53.7%), n = 3,238Treatment (with hypertension)NCHS DATA BRIEF 511 (PUBLISHED)Treatment (with hypertension): 51.2% (95% CI 48.6%–53.7%), n = 3,238Treatment (with hypertension)THIS CHAPTER (TAYLOR, DF 15)Control (with hypertension): 20.7% (95% CI 18.8%–22.7%), n = 3,242Control (with hypertension)NCHS DATA BRIEF 511 (PUBLISHED)Control (with hypertension): 20.7% (95% CI 18.8%–22.8%), n = 3,242Control (with hypertension)Percent
Show data
GroupEstimate forEstimate95% CIn
This chapter (Taylor, df 15)Prevalence (all adults)47.7%45.4%–49.9%6,084
NCHS Data Brief 511 (published)Prevalence (all adults)47.7%45.4%–49.9%6,084
This chapter (Taylor, df 15)Awareness (with hypertension)59.2%56.5%–61.9%3,240
NCHS Data Brief 511 (published)Awareness (with hypertension)59.2%56.4%–61.9%3,240
This chapter (Taylor, df 15)Treatment (with hypertension)51.2%48.7%–53.7%3,238
NCHS Data Brief 511 (published)Treatment (with hypertension)51.2%48.6%–53.7%3,238
This chapter (Taylor, df 15)Control (with hypertension)20.7%18.8%–22.7%3,242
NCHS Data Brief 511 (published)Control (with hypertension)20.7%18.8%–22.8%3,242
Figure 3.1.Hypertension is common and rarely controlled. Prevalence is a share of all adults; awareness, treatment, and control are each shares of adults with hypertension. The estimates match NCHS's published values within a tenth of a percentage point.Note: Chapter intervals: estimate ± t(15)·SE. NCHS publishes Korn–Graubard intervals, so endpoints can differ in the last digit.Source: NHANES August 2021–August 2023; NCHS Data Brief 511; chapter calculations

Figure 3.1 sets each estimate beside the published one. Agreement at the published rounding shows that the code reproduces NCHS's definitions. It does not show that the numbers are true. The brief is another estimate from the same sample, with the same protocol and the same nonresponse; benchmarks are not truth.Interval endpoints can differ in the last digit: NCHS publishes Korn–Graubard intervals, and this chapter uses the estimate plus or minus a t critical value times the standard error.

Two traps in the August 2021–August 2023 files

The examination weight is WTMEC2YR; WTMECPRP belongs to the pre-pandemic file. The medication item also changed: BPQ_L replaced BPQ040A and BPQ050A with BPQ150 and a new skip pattern, so only a yes counts as treated, and 33EstimandAnalytic adults with readings below 130/80 and unknown medication status, counted as not hypertensiveVarianceNone reportedSourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquetExternal benchmarkkeeping them reproduces the NCHS Data Brief 511 denominator of 6,084 adults with normal readings and unknown medication status stay in the denominator as not hypertensive.

Analysis Ledger

How many adults have hypertension, know it, treat it, and control it? (NHANES August 2021–August 2023)

Target population
U.S. civilian noninstitutionalized adults 18 and older, excluding pregnant women, August 2021–August 2023
Estimand
Finite-population proportions: hypertension among adults; awareness, treatment and control among adults with hypertension (NCHS Data Brief 511 definitions). Also the prevalence directly standardized to the 2000 U.S. population
Estimator
Weighted ratio (Hájek) means over domains of the declared design; age-adjusted prevalence = Σ_a s_a p̂_a over 18–39, 40–59, 60+
Explicit weights
WTMEC2YR, the examination weight: base weights for unequal selection probabilities with nonresponse and calibration adjustments. s_a = 2000 standard-population shares (0.4203, 0.3572, 0.2225) in the age-adjusted estimate
Implicit weights
None beyond the explicit weights; every estimate is a weighted mean of a 0/1 indicator
Source of randomness
Selection of PSUs and of people within PSUs in a stratified multistage sample; nonresponse treated as handled by the weight adjustments
Variance estimator
Taylor linearization with 15 masked strata and 30 PSUs (with-replacement approximation); design df 15; 95% intervals estimate ± t(15)·SE
Assumptions
Weights correct for differential nonresponse; the oscillometric protocol measures blood pressure comparably across participants; medication use is self-reported; averaging up to three readings defines the participant's blood pressure
Numbers reported
  • 47.7%47.7% percentEstimandCrude prevalence of hypertension among U.S. civilian noninstitutionalized adults 18+ (pregnant women excluded), Aug 2021-Aug 202395% CI45.4%–49.9% (t, df = 15)n6,084WeightWTMEC2YRVarianceTaylor linearization (design-based)SourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquetExternal benchmarkexternal benchmark: NCHS Data Brief 511 reports 47.7% (95% CI 45.4-49.9), SE 1.1, n = 6,084percent
  • 59.2%59.2% percentEstimandShare told by a health professional they have hypertension, among adults 18+ with hypertension (SBP >= 130 or DBP >= 80 mm Hg, or taking BP medication), Aug 2021-Aug 202395% CI56.5%–61.9% (t, df = 15)n3,240WeightWTMEC2YRVarianceTaylor linearization (design-based)SourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquetExternal benchmarkexternal benchmark: NCHS Data Brief 511 reports 59.2% (95% CI 56.4-61.9), SE 1.3, n = 3,240percent
  • 51.2%51.2% percentEstimandShare taking prescribed BP medication, among adults 18+ with hypertension (SBP >= 130 or DBP >= 80 mm Hg, or taking BP medication), Aug 2021-Aug 202395% CI48.7%–53.7% (t, df = 15)n3,238WeightWTMEC2YRVarianceTaylor linearization (design-based)SourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquetExternal benchmarkexternal benchmark: NCHS Data Brief 511 reports 51.2% (95% CI 48.6-53.7), SE 1.2, n = 3,238percent
  • 20.7%20.7% percentEstimandShare with SBP < 130 and DBP < 80 mm Hg, among adults 18+ with hypertension (SBP >= 130 or DBP >= 80 mm Hg, or taking BP medication), Aug 2021-Aug 202395% CI18.8%–22.7% (t, df = 15)n3,242WeightWTMEC2YRVarianceTaylor linearization (design-based)SourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquetExternal benchmarkexternal benchmark: NCHS Data Brief 511 reports 20.7% (95% CI 18.8-22.8), SE 0.9, n = 3,242percent
  • 44.5%44.5% percentEstimandAge-adjusted prevalence (2000 standard, 18-39/40-59/60+) among U.S. civilian noninstitutionalized adults 18+ (pregnant women excluded), Aug 2021-Aug 202395% CI42.1%–46.9% (t, df = 15)n6,084WeightWTMEC2YRVarianceTaylor linearization (design-based)SourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquetExternal benchmarkexternal benchmark: NCHS Data Brief 511 reports 44.5% (95% CI 42.1-46.9), SE 1.1, n = 6,084percent

Three standard errors for one number

The prevalence estimate is a weighted ratio, the Hájek estimator:

p^=∑iwiyi∑iwi,\hat p = \frac{\sum_i w_i y_i}{\sum_i w_i},

where yiy_i is 1 for hypertension and wiw_i is the examination weight. With correct inclusion weights, p^\hat p is a consistent estimator of one specified finite-population quantity: the share of the target population with hypertension. The weights define what the formula estimates. They do not say how far the estimate would move if the survey were run again.

Three standard errors answer three different questions about that repetition. The naive standard error imagines repeated simple random samples of examined adults and ignores the weights. The weights-only standard error charges for unequal weights but still treats each respondent as an independent draw. The full-design standard error describes the sample NHANES draws: a few dozen primary sampling units (PSUs), counties or groups of counties, selected within strata, with hundreds of people examined in each.

Predict first

The sampler below is the one from Chapter 0. Its second stage draws repeated samples of the same size two ways: simple random samples of people, and samples of neighborhoods with a fixed number of residents in each. Before you open that stage, guess whether the clustered estimates spread more or less than the simple random ones, and how the answer changes as fewer neighborhoods supply more residents each.

One population, three questions
A synthetic population of 20,000 adults in 200 neighbourhoods (version 1.0.0, population seed 20260910). Each stage changes one thing.
Stage
4×
Selection probability: 13.8% for G, 3.4% for everyone else. Design weight d = 1/π.
Seed 1n = 1,000
Population
G 15%
not G
This sample
G 42%
not G
6%8%10%12%14%16%18%20%22%24%Unweighted mean 16.2%Weighted (Hájek) mean 11.7%Simulated population truth 12.4%

Across 200 samples at this setting the unweighted mean averages 16.5% and the weighted mean 12.3%, against a truth of 12.4%. Members of G are uninsured more often (26% against 10%), so a sample that over-represents them overstates the rate unless each person counts 1/π times.

What is held fixed. The population, the outcome (uninsured), and the sample size. Only who is likely to enter the sample changes; the design weights d = 1/π undo exactly that.

The clustered estimates spread more than the simple random ones, the gap grows as fewer neighborhoods supply more residents each, and the center of the distribution does not move. Two people examined in the same county share its diet, its incomes, its doctors, and its air; the second one tells the survey less than a stranger from a new county would. That is the pattern behind every NHANES standard error.

Predict first

For hypertension prevalence, will the full-design standard error be smaller than the naive one, about the same, or larger? By how much? And which of the two simpler standard errors will it be closer to?

Taylor linearization turns the picture into a formula. Replace each respondent by a linearized value zi=wi(yi−p^)/∑jwjz_i = w_i(y_i - \hat p)/\sum_j w_j, add those values within each PSU to get a total zhjz_{hj} for PSU jj in stratum hh, and compare PSUs within strata:

Var⁡^(p^)=∑hnhnh−1∑j=1nh(zhj−zˉh)2.\widehat{\Var}(\hat p) = \sum_{h} \frac{n_h}{n_h - 1} \sum_{j=1}^{n_h} \left(z_{hj} - \bar z_h\right)^2 .

PSUs enter as the units of independent information. Strata enter only through the within-stratum comparison, which keeps differences between strata out of the variance; that is where stratification's precision gain comes from (Lumley 2010; Heeringa, West, and Berglund 2017). The weights-only formula is the same expression with every respondent as its own PSU and a single stratum, and the naive formula is p^(1−p^)/(n−1)\sqrt{\hat p(1-\hat p)/(n-1)}.

One estimate, three standard errors

Table of five hypertension estimates for August 2021–August 2023 with their naive, weights-only and full-design standard errors, design effects between about 1.7 and 3.1, and 15 design degrees of freedom.
EstimateValuenSE, naive (pp)SE, weights only (pp)SE, full design (pp)DEFFDesign df
Hypertension, crude47.7%6,0840.640.791.062.72×15
Hypertension, age-adjusted44.5%6,0840.640.771.123.07×15
Awareness59.2%3,2400.861.091.262.12×15
Treatment51.2%3,2380.881.091.181.80×15
Control20.7%3,2420.710.820.931.70×15
Figure 3.2.The full-design standard error is well above both simpler ones, and by how much depends on the estimand.Note: Naive: √(p(1−p)/(n−1)), ignoring weights and design. Weights only: every respondent its own PSU, no strata (the HC1 sandwich for a weighted mean). Full design: Taylor linearization with SDMVSTRA and SDMVPSU. DEFF = (full-design SE / naive SE)².Source: NHANES August 2021–August 2023; chapter calculations

For prevalence, the three standard errors are 0.640.64 percentage pointsEstimandStandard error of crude prevalence, naive iid, percentage pointsn6,084WeightWTMEC2YRVarianceNone reportedSourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquet, 0.790.79 percentage pointsEstimandStandard error of crude prevalence, weights-only (HC1-type), percentage pointsn6,084WeightWTMEC2YRVarianceWeights only: computed without the survey design, so not a design-based standard errorSourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquet, and 1.061.06 percentage pointsEstimandStandard error of crude prevalence, full-design Taylor, percentage pointsn6,084WeightWTMEC2YRVarianceTaylor linearization (design-based)SourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquet percentage points (Figure 3.2). The ratio of the design variance to the naive variance is the design effect, DEFF\DEFF (Kish 1965): here 2.722.72EstimandDesign effect (Taylor variance / SRS-with-replacement variance), prevalence, Aug 2021-Aug 2023n6,084WeightWTMEC2YRVarianceTaylor linearization (design-based)SourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquet. It factors exactly into two pieces. The weighting factor, the squared ratio of the weights-only to the naive standard error, is 1.511.51EstimandWeighting factor: (weights-only SE / naive SE) squared, crude prevalence, Aug 2021-Aug 2023WeightWTMEC2YRVarianceNone reportedSourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquet. The clustering-and-stratification factor, the squared ratio of the design to the weights-only standard error, is 1.801.80EstimandClustering-and-stratification factor: (design SE / weights-only SE) squared, crude prevalence, Aug 2021-Aug 2023WeightWTMEC2YRVarianceNone reportedSourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquet. For prevalence, the 6,0846,084EstimandExamined adults 18+ in the analytic sample (not pregnant, at least one valid BP reading)n6,084VarianceNone reportedSourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquetExternal benchmarkNCHS Data Brief 511: n = 6,084 examined adults carry about as much information as 2,2392,239EstimandDesign-based effective sample size n / DEFF, crude prevalencen6,084VarianceNone reportedSourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquet adults drawn at random.

Caution

A slogan that needs correcting in both halves

"Weights get the point estimate, the design gets the uncertainty." The weights help define the estimator, and they also shape its variance twice over: unequal weights inflate it, and the weights are themselves built from the sample, since nonresponse and calibration adjustments are estimates. The repeated-sampling variance therefore depends on the sampling design and on how the weights were constructed. Taylor linearization applied to the final weights treats them as fixed; replicate methods that repeat the weighting steps in every replicate do not.

Degrees of freedom are the other half of the story. The public August 2021–August 2023 file has 3030EstimandMasked variance PSUs, Aug 2021-Aug 2023 MEC sampleVarianceNone reportedSourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquet masked PSUs in 1515EstimandMasked variance strata, Aug 2021-Aug 2023 MEC sampleVarianceNone reportedSourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquet strata, and the usual Taylor rule, PSUs minus strata, gives 1515EstimandDesign degrees of freedom (#PSU - #strata), Aug 2021-Aug 2023VarianceNone reportedSourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquet degrees of freedom: the number of independent within-stratum comparisons behind the variance estimate. With so few, the 97.5th percentile of t is 2.132.13Estimand97.5th percentile of t with 15 dfVarianceNone reportedSourcescipy.stats.t rather than 1.961.96Estimand97.5th percentile of the standard normalVarianceNone reportedSourcescipy.stats.norm. Together with the larger standard error, the design-based interval is 1.81.8EstimandFull-design 95% CI width (t, df 15) divided by naive 95% CI width, crude prevalenceVarianceNone reportedSourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquet times as wide as the naive one. The design declaration behind these numbers is two lines in either language (The tools).

There is no single NHANES design effect

A design effect belongs to an estimator, for an outcome, in a domain, under a design; it is not a constant of the survey. For August 2021–August 2023 it is 2.722.72EstimandDesign effect (Taylor variance / SRS-with-replacement variance), prevalence, Aug 2021-Aug 2023n6,084WeightWTMEC2YRVarianceTaylor linearization (design-based)SourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquet for prevalence, 2.122.12EstimandDesign effect (Taylor variance / SRS-with-replacement variance), awareness, Aug 2021-Aug 2023n3,240WeightWTMEC2YRVarianceTaylor linearization (design-based)SourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquet for awareness, 1.801.80EstimandDesign effect (Taylor variance / SRS-with-replacement variance), treatment, Aug 2021-Aug 2023n3,238WeightWTMEC2YRVarianceTaylor linearization (design-based)SourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquet for treatment, 1.701.70EstimandDesign effect (Taylor variance / SRS-with-replacement variance), control, Aug 2021-Aug 2023n3,242WeightWTMEC2YRVarianceTaylor linearization (design-based)SourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquet for control, and 2.302.30EstimandDesign effect, hypertension prevalence among adults 18-39, Aug 2021-Aug 2023n1,712WeightWTMEC2YRVarianceTaylor linearization (design-based)SourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquet for prevalence among adults 18–39 (Figure 3.3). The pre-pandemic file gives 5.295.29EstimandDesign effect, crude hypertension prevalence, 2017-March 2020n7,948WeightWTMECPRPVarianceTaylor linearization (design-based)SourceNHANES 2017-March 2020 pre-pandemic (P_ files); nhanes_analysis.parquet + nhanes_full_1999_2023.parquet (BPQ040A/BPQ050A) for the same prevalence estimand. Most of that difference is weighting. The 2017–March 2020 sample oversampled by race, Hispanic origin, and income, and its weighting factor is 2.342.34EstimandWeighting factor, crude prevalence, 2017-March 2020WeightWTMECPRPVarianceNone reportedSourceNHANES 2017-March 2020 pre-pandemic (P_ files); nhanes_analysis.parquet + nhanes_full_1999_2023.parquet (BPQ040A/BPQ050A); the August 2021–August 2023 sample did not oversample. An effective sample size is always an effective sample size for something: ndesign(θ^)=n/DEFF(θ^)\ndesign(\hat\theta) = n/\DEFF(\hat\theta).

There is no single NHANES design effect

Design effect by estimand and survey period

AUG 2021–AUG 2023Prevalence: 2.72, n = 6,084PrevalenceAwareness: 2.12, n = 3,240AwarenessTreatment: 1.80, n = 3,238TreatmentControl: 1.70, n = 3,242ControlPrevalence, ages 18–39: 2.30, n = 1,712Prevalence, ages 18–392017–MAR 2020Prevalence: 5.29, n = 7,948PrevalenceAwareness: 3.25, n = 4,297AwarenessTreatment: 3.15, n = 4,295TreatmentControl: 1.62, n = 4,305ControlPrevalence, ages 18–39: 3.03, n = 2,608Prevalence, ages 18–39Design effect (variance ÷ simple-random-sample variance)AUG 2021–AUG 2023Prevalence: 2.72, n = 6,084PrevalenceAwareness: 2.12, n = 3,240AwarenessTreatment: 1.80, n = 3,238TreatmentControl: 1.70, n = 3,242ControlPrevalence, ages 18–39: 2.30, n = 1,712Prevalence, ages 18–392017–MAR 2020Prevalence: 5.29, n = 7,948PrevalenceAwareness: 3.25, n = 4,297AwarenessTreatment: 3.15, n = 4,295TreatmentControl: 1.62, n = 4,305ControlPrevalence, ages 18–39: 3.03, n = 2,608Prevalence, ages 18–39Design effect (variance ÷ simple-random-sample variance)
Show data
GroupEstimate forEstimaten
Aug 2021–Aug 2023Prevalence2.726,084
Aug 2021–Aug 2023Awareness2.123,240
Aug 2021–Aug 2023Treatment1.803,238
Aug 2021–Aug 2023Control1.703,242
Aug 2021–Aug 2023Prevalence, ages 18–392.301,712
2017–Mar 2020Prevalence5.297,948
2017–Mar 2020Awareness3.254,297
2017–Mar 2020Treatment3.154,295
2017–Mar 2020Control1.624,305
2017–Mar 2020Prevalence, ages 18–393.032,608
Figure 3.3.Design effects vary across estimands and survey periods; no single number describes NHANES.Note: Subgroup pre-specified before estimation. The 2017–March 2020 sample oversampled by race, Hispanic origin and income; the August 2021–August 2023 sample did not.Source: NHANES 2017–March 2020 and August 2021–August 2023; chapter calculations

The Moulton bridge

Predict first

Suppose two people in the same PSU are barely more alike than two strangers, an intraclass correlation well under one percent. Can that nearly double a variance?

Economists know the clustering component under another name. For a regressor that is constant within clusters, with equal cluster sizes mˉ\bar m and equicorrelated errors, Moulton (1990) showed that conventional variances understate the truth by the factor

1+(mˉ−1)ρ.1 + (\bar m - 1)\rho .

NHANES examines about 203203EstimandAverage analytic-sample size per PSU (6,084 adults / 30 PSUs)VarianceNone reportedSourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquet analytic-sample adults per PSU, so an intraclass correlation of only 0.0040.004EstimandIntraclass correlation implied by the observed clustering factor under the equal-cluster Moulton formula 1 + (m - 1) rhoVarianceNone reportedSourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquetNoteBack-of-envelope: ignores unequal cluster sizes and the stratification gain folded into the factor reproduces the clustering factor of 1.801.80EstimandClustering-and-stratification factor: (design SE / weights-only SE) squared, crude prevalence, Aug 2021-Aug 2023WeightWTMEC2YRVarianceNone reportedSourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquet. The answer to the prediction is yes: with clusters that large, a correlation that small nearly doubles the variance. Read the formula as a bridge, not an identity. The Moulton factor is a special-case regression analogue of the clustering component of a design effect: it assumes equal cluster sizes, leaves out the stratification gain, and says nothing about the weighting factor. Chapter 6 takes up clustering in regression.

Did control get worse?

The comparison needs two independent samples measured the same way. The pre-pandemic file (2017–March 2020, weight WTMECPRP, 2525EstimandDesign degrees of freedom, 2017-March 2020 pre-pandemic fileVarianceNone reportedSourceNHANES 2017-March 2020 pre-pandemic (P_ files); nhanes_analysis.parquet + nhanes_full_1999_2023.parquet (BPQ040A/BPQ050A) design degrees of freedom) and the August 2021–August 2023 file both used the oscillometric device. The separate 2017–2018 cycle stays out: the pre-pandemic file already contains its participants under new identifiers, so pooling the two would count them twice.

Nationally, nothing moved detectably. Awareness was 60.2%60.2% percentEstimandAwareness, adults with hypertension, 2017-March 202095% CI57.4%–63.0% (t, df = 25)n4,297WeightWTMECPRPVarianceTaylor linearization (design-based)SourceNHANES 2017-March 2020 pre-pandemic (P_ files); nhanes_analysis.parquet + nhanes_full_1999_2023.parquet (BPQ040A/BPQ050A)External benchmarkexternal benchmark: NCHS Data Brief 511 reports 60.2% (95% CI 57.4-63.0), SE 1.3, n = 4,297 before and 59.2%59.2% percentEstimandShare told by a health professional they have hypertension, among adults 18+ with hypertension (SBP >= 130 or DBP >= 80 mm Hg, or taking BP medication), Aug 2021-Aug 202395% CI56.5%–61.9% (t, df = 15)n3,240WeightWTMEC2YRVarianceTaylor linearization (design-based)SourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquetExternal benchmarkexternal benchmark: NCHS Data Brief 511 reports 59.2% (95% CI 56.4-61.9), SE 1.3, n = 3,240 after, treatment 50.3%50.3% percentEstimandTreatment, adults with hypertension, 2017-March 202095% CI47.5%–53.1% (t, df = 25)n4,295WeightWTMECPRPVarianceTaylor linearization (design-based)SourceNHANES 2017-March 2020 pre-pandemic (P_ files); nhanes_analysis.parquet + nhanes_full_1999_2023.parquet (BPQ040A/BPQ050A)External benchmarkexternal benchmark: NCHS Data Brief 511 reports 50.3% (95% CI 47.5-53.1), SE 1.4, n = 4,295 and 51.2%51.2% percentEstimandShare taking prescribed BP medication, among adults 18+ with hypertension (SBP >= 130 or DBP >= 80 mm Hg, or taking BP medication), Aug 2021-Aug 202395% CI48.7%–53.7% (t, df = 15)n3,238WeightWTMEC2YRVarianceTaylor linearization (design-based)SourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquetExternal benchmarkexternal benchmark: NCHS Data Brief 511 reports 51.2% (95% CI 48.6-53.7), SE 1.2, n = 3,238, control 22.2%22.2% percentEstimandControl, adults with hypertension, 2017-March 202095% CI20.5%–23.9% (t, df = 25)n4,305WeightWTMECPRPVarianceTaylor linearization (design-based)SourceNHANES 2017-March 2020 pre-pandemic (P_ files); nhanes_analysis.parquet + nhanes_full_1999_2023.parquet (BPQ040A/BPQ050A)External benchmarkexternal benchmark: NCHS Data Brief 511 reports 22.2% (95% CI 20.6-23.9), SE 0.8, n = 4,305 and 20.7%20.7% percentEstimandShare with SBP < 130 and DBP < 80 mm Hg, among adults 18+ with hypertension (SBP >= 130 or DBP >= 80 mm Hg, or taking BP medication), Aug 2021-Aug 202395% CI18.8%–22.7% (t, df = 15)n3,242WeightWTMEC2YRVarianceTaylor linearization (design-based)SourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquetExternal benchmarkexternal benchmark: NCHS Data Brief 511 reports 20.7% (95% CI 18.8-22.8), SE 0.9, n = 3,242, a change of −1.5 (95% CI −4.0 to 1.0)−1.5 percentage pointsEstimandChange in control (adults with hypertension; All adults), Aug 2021-Aug 2023 minus 2017-March 2020, percentage points95% CI−4.0 to 1.0 (t, df = 34)n7,547WeightWTMEC2YR (2021-2023) / WTMECPRP (2017-March 2020)VarianceTaylor linearization (design-based)SourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquet; NHANES 2017-March 2020 pre-pandemic (P_ files); nhanes_analysis.parquet + nhanes_full_1999_2023.parquet (BPQ040A/BPQ050A)Notenaive p = 0.126; design p = 0.244 (Satterthwaite df 34.4) percentage points. Naive and full-design tests agree that no stage changed (for control, p = 0.1260.126EstimandTwo-sided naive p-value for chg_controlVarianceNone reportedSourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquet; NHANES 2017-March 2020 pre-pandemic (P_ files); nhanes_analysis.parquet + nhanes_full_1999_2023.parquet (BPQ040A/BPQ050A) and 0.2440.244EstimandTwo-sided full-design p-value for chg_controlVarianceNone reportedSourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquet; NHANES 2017-March 2020 pre-pandemic (P_ files); nhanes_analysis.parquet + nhanes_full_1999_2023.parquet (BPQ040A/BPQ050A)), which matches the NCHS finding.

The conclusions part company in subgroups. Across the 24 pre-specified comparisons, four stages in all adults, men, women, and three age groups, naive intervals flag 33EstimandNumber of the 24 period comparisons (4 cascade stages x 6 groups) with p < 0.05 under naive iid (normal)VarianceNone reportedSourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquet; NHANES 2017-March 2020 pre-pandemic (P_ files); nhanes_analysis.parquet + nhanes_full_1999_2023.parquet (BPQ040A/BPQ050A), weights-only intervals flag 11EstimandNumber of the 24 period comparisons (4 cascade stages x 6 groups) with p < 0.05 under weights-onlyVarianceNone reportedSourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquet; NHANES 2017-March 2020 pre-pandemic (P_ files); nhanes_analysis.parquet + nhanes_full_1999_2023.parquet (BPQ040A/BPQ050A), and full-design intervals flag 11EstimandNumber of the 24 period comparisons (4 cascade stages x 6 groups) with p < 0.05 under full-design Taylor (t, Satterthwaite df)VarianceNone reportedSourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquet; NHANES 2017-March 2020 pre-pandemic (P_ files); nhanes_analysis.parquet + nhanes_full_1999_2023.parquet (BPQ040A/BPQ050A) (Figure 3.4; Figure 3.5 lists all 24). The design-based test adds the two periods' Taylor variances and uses a t reference with Satterthwaite degrees of freedom built from 1515EstimandDesign degrees of freedom (#PSU - #strata), Aug 2021-Aug 2023VarianceNone reportedSourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquet and 2525EstimandDesign degrees of freedom, 2017-March 2020 pre-pandemic fileVarianceNone reportedSourceNHANES 2017-March 2020 pre-pandemic (P_ files); nhanes_analysis.parquet + nhanes_full_1999_2023.parquet (BPQ040A/BPQ050A). Men's control, from the opening, is one of the naive flags. Prevalence among adults 60 and older is another: a change of −2.5 (95% CI −6.2 to 1.1)−2.5 percentage pointsEstimandChange in prevalence (all adults; Ages 60+), Aug 2021-Aug 2023 minus 2017-March 2020, percentage points95% CI−6.2 to 1.1 (t, df = 37)n5,497WeightWTMEC2YR (2021-2023) / WTMECPRP (2017-March 2020)VarianceTaylor linearization (design-based)SourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquet; NHANES 2017-March 2020 pre-pandemic (P_ files); nhanes_analysis.parquet + nhanes_full_1999_2023.parquet (BPQ040A/BPQ050A)Notenaive p = 0.035; design p = 0.170 (Satterthwaite df 37.4) percentage points, with a naive p of 0.0350.035EstimandTwo-sided naive p-value for chg_prev_60VarianceNone reportedSourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquet; NHANES 2017-March 2020 pre-pandemic (P_ files); nhanes_analysis.parquet + nhanes_full_1999_2023.parquet (BPQ040A/BPQ050A) and a design p of 0.1700.170EstimandTwo-sided full-design p-value for chg_prev_60VarianceNone reportedSourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquet; NHANES 2017-March 2020 pre-pandemic (P_ files); nhanes_analysis.parquet + nhanes_full_1999_2023.parquet (BPQ040A/BPQ050A). The one change whose design-based interval excludes zero is awareness among adults 18–39 with hypertension, −8.4 (95% CI −16.6 to −0.2)−8.4 percentage pointsEstimandChange in awareness (adults with hypertension; Ages 18–39), Aug 2021-Aug 2023 minus 2017-March 2020, percentage points95% CI−16.6 to −0.2 (t, df = 38)n1,016WeightWTMEC2YR (2021-2023) / WTMECPRP (2017-March 2020)VarianceTaylor linearization (design-based)SourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquet; NHANES 2017-March 2020 pre-pandemic (P_ files); nhanes_analysis.parquet + nhanes_full_1999_2023.parquet (BPQ040A/BPQ050A)Notenaive p = 0.004; design p = 0.044 (Satterthwaite df 38.4) percentage points (naive p = 0.0040.004EstimandTwo-sided naive p-value for chg_aware_1839VarianceNone reportedSourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquet; NHANES 2017-March 2020 pre-pandemic (P_ files); nhanes_analysis.parquet + nhanes_full_1999_2023.parquet (BPQ040A/BPQ050A), design p = 0.0440.044EstimandTwo-sided full-design p-value for chg_aware_1839VarianceNone reportedSourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquet; NHANES 2017-March 2020 pre-pandemic (P_ files); nhanes_analysis.parquet + nhanes_full_1999_2023.parquet (BPQ040A/BPQ050A)). With 24 tests at the 5 percent level, about 24×0.05=1.224 \times 0.05 = 1.2 rejections are expected even if nothing changed, so this one is not established as a real change either. The design moved no estimate; it widened the intervals, and two of the three naive flags no longer exclude zero.

Did the cascade change after the pandemic?

Aug 2021–Aug 2023 minus 2017–March 2020, percentage points, 95% intervals

  • Naive
  • Design-based
NAIVE IID INTERVALPrevalence: −0.4 (95% CI −2.1–1.2)PrevalenceFULL-DESIGN INTERVALPrevalence: −0.4 (95% CI −3.8–2.9)PrevalenceNAIVE IID INTERVALPrevalence, ages 60+: −2.5 (95% CI −4.9–−0.2)Prevalence, ages 60+FULL-DESIGN INTERVALPrevalence, ages 60+: −2.5 (95% CI −6.2–1.1)Prevalence, ages 60+NAIVE IID INTERVALAwareness: −1.0 (95% CI −3.3–1.2)AwarenessFULL-DESIGN INTERVALAwareness: −1.0 (95% CI −4.7–2.7)AwarenessNAIVE IID INTERVALAwareness, ages 18–39: −8.4 (95% CI −14.2–−2.7)Awareness, ages 18–39FULL-DESIGN INTERVALAwareness, ages 18–39: −8.4 (95% CI −16.6–−0.2)Awareness, ages 18–39NAIVE IID INTERVALTreatment: 0.9 (95% CI −1.4–3.2)TreatmentFULL-DESIGN INTERVALTreatment: 0.9 (95% CI −2.7–4.5)TreatmentNAIVE IID INTERVALControl: −1.5 (95% CI −3.3–0.4)ControlFULL-DESIGN INTERVALControl: −1.5 (95% CI −4.0–1.0)ControlNAIVE IID INTERVALControl, men: −3.0 (95% CI −5.6–−0.4)Control, menFULL-DESIGN INTERVALControl, men: −3.0 (95% CI −6.4–0.4)Control, menChange (percentage points)NAIVE IID INTERVALPrevalence: −0.4 (95% CI −2.1–1.2)PrevalenceFULL-DESIGN INTERVALPrevalence: −0.4 (95% CI −3.8–2.9)PrevalenceNAIVE IID INTERVALPrevalence, ages 60+: −2.5 (95% CI −4.9–−0.2)Prevalence, ages 60+FULL-DESIGN INTERVALPrevalence, ages 60+: −2.5 (95% CI −6.2–1.1)Prevalence, ages 60+NAIVE IID INTERVALAwareness: −1.0 (95% CI −3.3–1.2)AwarenessFULL-DESIGN INTERVALAwareness: −1.0 (95% CI −4.7–2.7)AwarenessNAIVE IID INTERVALAwareness, ages 18–39: −8.4 (95% CI −14.2–−2.7)Awareness, ages 18–39FULL-DESIGN INTERVALAwareness, ages 18–39: −8.4 (95% CI −16.6–−0.2)Awareness, ages 18–39NAIVE IID INTERVALTreatment: 0.9 (95% CI −1.4–3.2)TreatmentFULL-DESIGN INTERVALTreatment: 0.9 (95% CI −2.7–4.5)TreatmentNAIVE IID INTERVALControl: −1.5 (95% CI −3.3–0.4)ControlFULL-DESIGN INTERVALControl: −1.5 (95% CI −4.0–1.0)ControlNAIVE IID INTERVALControl, men: −3.0 (95% CI −5.6–−0.4)Control, menFULL-DESIGN INTERVALControl, men: −3.0 (95% CI −6.4–0.4)Control, menChange (percentage points)
Show data
GroupEstimate forEstimate95% CI
Naive iid intervalPrevalence−0.4−2.1–1.2
Full-design intervalPrevalence−0.4−3.8–2.9
Naive iid intervalPrevalence, ages 60+−2.5−4.9–−0.2
Full-design intervalPrevalence, ages 60+−2.5−6.2–1.1
Naive iid intervalAwareness−1.0−3.3–1.2
Full-design intervalAwareness−1.0−4.7–2.7
Naive iid intervalAwareness, ages 18–39−8.4−14.2–−2.7
Full-design intervalAwareness, ages 18–39−8.4−16.6–−0.2
Naive iid intervalTreatment0.9−1.4–3.2
Full-design intervalTreatment0.9−2.7–4.5
Naive iid intervalControl−1.5−3.3–0.4
Full-design intervalControl−1.5−4.0–1.0
Naive iid intervalControl, men−3.0−5.6–−0.4
Full-design intervalControl, men−3.0−6.4–0.4
Figure 3.4.Naive intervals exclude zero for three subgroup changes; full-design intervals exclude zero for one.Note: Overall stages plus the three subgroup comparisons (of 24) that naive intervals flag. Design intervals use t with Satterthwaite df from 15 and 25.Source: NHANES 2017–March 2020 and August 2021–August 2023; chapter calculations
All 24 period comparisons

All 24 period comparisons

Table of 24 comparisons of hypertension cascade estimates between 2017–March 2020 and August 2021–August 2023 by stage and group, with naive and full-design p-values.
StageGroup2017–Mar 2020Aug 2021–Aug 2023Change (pp)p, naivep, full design
PrevalenceAll adults48.1%47.7%−0.40.6150.799
PrevalenceMen50.5%50.8%0.30.8080.885
PrevalenceWomen45.7%44.6%−1.10.3350.582
PrevalenceAges 18–3923.4%23.4%0.00.9780.986
PrevalenceAges 40–5952.4%52.5%0.00.9920.995
PrevalenceAges 60+74.1%71.6%−2.50.0350.170
AwarenessAll adults60.2%59.2%−1.00.3750.585
AwarenessMen58.2%55.2%−3.00.0640.262
AwarenessWomen62.3%63.6%1.30.4300.557
AwarenessAges 18–3935.6%27.2%−8.40.0040.044
AwarenessAges 40–5955.3%56.7%1.40.5100.698
AwarenessAges 60+73.9%73.7%−0.20.8800.920
TreatmentAll adults50.3%51.2%0.90.4320.613
TreatmentMen46.3%46.7%0.40.8080.878
TreatmentWomen54.5%56.1%1.60.3290.460
TreatmentAges 18–3916.6%13.9%−2.60.2500.349
TreatmentAges 40–5943.3%47.1%3.80.0720.249
TreatmentAges 60+69.3%69.1%−0.30.8460.894
ControlAll adults22.2%20.7%−1.50.1260.244
ControlMen21.9%18.9%−3.00.0220.081
ControlWomen22.5%22.8%0.30.8500.889
ControlAges 18–395.5%4.5%−1.00.4540.484
ControlAges 40–5918.8%18.1%−0.70.6490.746
ControlAges 60+31.6%29.2%−2.40.1000.329
Figure 3.5.Naive and full-design p-values for every stage and group; highlighted rows reach the 5 percent level under at least one method.Note: Highlighted rows: p < 0.05 under at least one method. No adjustment for multiple comparisons.Source: NHANES; chapter calculations
Analysis Ledger

Did awareness, treatment, or control change after the pandemic?

Target population
U.S. civilian noninstitutionalized adults 18+ with hypertension (pregnant women excluded) in 2017–March 2020 and in August 2021–August 2023
Estimand
Differences between the two periods in finite-population proportions, overall and in five pre-specified groups (24 comparisons)
Estimator
Difference of two independent weighted ratio means
Explicit weights
WTMECPRP (2017–March 2020 pre-pandemic file) and WTMEC2YR (August 2021–August 2023)
Implicit weights
None
Source of randomness
Two independent stratified multistage samples
Variance estimator
Sum of the two Taylor variances (15 and 25 df), t with Satterthwaite df; compared with naive iid and weights-only variances
Assumptions
Comparable definitions and instruments (oscillometric in both periods; medication question changed wording and skip pattern in 2021–2023); no adjustment for multiple comparisons, as in NCHS reports
Numbers reported
  • −1.5−1.5 percentage pointsEstimandChange in control (adults with hypertension; All adults), Aug 2021-Aug 2023 minus 2017-March 2020, percentage points95% CI−4.0 to 1.0 (t, df = 34)n7,547WeightWTMEC2YR (2021-2023) / WTMECPRP (2017-March 2020)VarianceTaylor linearization (design-based)SourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquet; NHANES 2017-March 2020 pre-pandemic (P_ files); nhanes_analysis.parquet + nhanes_full_1999_2023.parquet (BPQ040A/BPQ050A)Notenaive p = 0.126; design p = 0.244 (Satterthwaite df 34.4)percentage points
  • 60.2%60.2% percentEstimandAwareness, adults with hypertension, 2017-March 202095% CI57.4%–63.0% (t, df = 25)n4,297WeightWTMECPRPVarianceTaylor linearization (design-based)SourceNHANES 2017-March 2020 pre-pandemic (P_ files); nhanes_analysis.parquet + nhanes_full_1999_2023.parquet (BPQ040A/BPQ050A)External benchmarkexternal benchmark: NCHS Data Brief 511 reports 60.2% (95% CI 57.4-63.0), SE 1.3, n = 4,297percent
  • 50.3%50.3% percentEstimandTreatment, adults with hypertension, 2017-March 202095% CI47.5%–53.1% (t, df = 25)n4,295WeightWTMECPRPVarianceTaylor linearization (design-based)SourceNHANES 2017-March 2020 pre-pandemic (P_ files); nhanes_analysis.parquet + nhanes_full_1999_2023.parquet (BPQ040A/BPQ050A)External benchmarkexternal benchmark: NCHS Data Brief 511 reports 50.3% (95% CI 47.5-53.1), SE 1.4, n = 4,295percent
  • 22.2%22.2% percentEstimandControl, adults with hypertension, 2017-March 202095% CI20.5%–23.9% (t, df = 25)n4,305WeightWTMECPRPVarianceTaylor linearization (design-based)SourceNHANES 2017-March 2020 pre-pandemic (P_ files); nhanes_analysis.parquet + nhanes_full_1999_2023.parquet (BPQ040A/BPQ050A)External benchmarkexternal benchmark: NCHS Data Brief 511 reports 22.2% (95% CI 20.6-23.9), SE 0.8, n = 4,305percent
  • 33EstimandNumber of the 24 period comparisons (4 cascade stages x 6 groups) with p < 0.05 under naive iid (normal)VarianceNone reportedSourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquet; NHANES 2017-March 2020 pre-pandemic (P_ files); nhanes_analysis.parquet + nhanes_full_1999_2023.parquet (BPQ040A/BPQ050A)
  • 11EstimandNumber of the 24 period comparisons (4 cascade stages x 6 groups) with p < 0.05 under full-design Taylor (t, Satterthwaite df)VarianceNone reportedSourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquet; NHANES 2017-March 2020 pre-pandemic (P_ files); nhanes_analysis.parquet + nhanes_full_1999_2023.parquet (BPQ040A/BPQ050A)

That answers the opening question, for a comparison of two independent samples. The same data hold four further lessons about weights and designs, and a second survey supplies the case researchers meet more often: two groups inside one sample.

Age standardization: a third kind of weight

Predict first

Crude prevalence is higher among men than among women by 6.36.3 percentage pointsEstimandMen minus women, crude hypertension prevalence (percentage points), Aug 2021-Aug 202395% CI2.9 to 9.6 (t, df = 15)n6,084WeightWTMEC2YRVarianceTaylor linearization (design-based)SourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquet percentage points, and women in the population are older on average. After both groups are put on one age distribution, will the gap shrink or grow?

Survey weights wiw_i repair representation: they make the sample stand for the population that existed in 2021–2023, with its own age structure. Standardization weights sas_a do something else. They replace that age structure with a fixed standard, which redefines the population in which the comparison is made:

p^adj=∑asap^a,sa=(0.4203, 0.3572, 0.2225),\hat p^{\text{adj}} = \sum_{a} s_a \hat p_a, \qquad s_a = (0.4203,\ 0.3572,\ 0.2225),

where p^a\hat p_a is the survey-weighted prevalence in the age groups 18–39, 40–59, and 60 and older, and sas_a is each group's share of the 2000 U.S. standard population, the NCHS convention. The sas_a are constants, so the variance comes from linearizing the three p^a\hat p_a jointly under the design.

Crude prevalence is 47.7%47.7% percentEstimandCrude prevalence of hypertension among U.S. civilian noninstitutionalized adults 18+ (pregnant women excluded), Aug 2021-Aug 202395% CI45.4%–49.9% (t, df = 15)n6,084WeightWTMEC2YRVarianceTaylor linearization (design-based)SourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquetExternal benchmarkexternal benchmark: NCHS Data Brief 511 reports 47.7% (95% CI 45.4-49.9), SE 1.1, n = 6,084; age-adjusted prevalence is 44.5% (95% CI 42.1%–46.9%)44.5% percentEstimandAge-adjusted prevalence (2000 standard, 18-39/40-59/60+) among U.S. civilian noninstitutionalized adults 18+ (pregnant women excluded), Aug 2021-Aug 202395% CI42.1%–46.9% (t, df = 15)n6,084WeightWTMEC2YRVarianceTaylor linearization (design-based)SourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquetExternal benchmarkexternal benchmark: NCHS Data Brief 511 reports 44.5% (95% CI 42.1-46.9), SE 1.1, n = 6,084 (Figure 3.6). For men the two are 50.8%50.8% percentEstimandCrude hypertension prevalence, men 18+, Aug 2021-Aug 202395% CI48.5%–53.2% (t, df = 15)n2,776WeightWTMEC2YRVarianceTaylor linearization (design-based)SourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquetExternal benchmarkexternal benchmark: NCHS Data Brief 511 reports 50.8% (95% CI 48.4-53.2), SE 1.1, n = 2,776 and 48.8%48.8% percentEstimandAge-adjusted hypertension prevalence, men 18+, Aug 2021-Aug 202395% CI46.1%–51.4% (t, df = 15)n2,776WeightWTMEC2YRVarianceTaylor linearization (design-based)SourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquetExternal benchmarkexternal benchmark: NCHS Data Brief 511 reports 48.8% (95% CI 46.2-51.4), SE 1.2, n = 2,776; for women, 44.6%44.6% percentEstimandCrude hypertension prevalence, women 18+, Aug 2021-Aug 202395% CI41.4%–47.7% (t, df = 15)n3,308WeightWTMEC2YRVarianceTaylor linearization (design-based)SourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquetExternal benchmarkexternal benchmark: NCHS Data Brief 511 reports 44.6% (95% CI 41.4-47.8), SE 1.5, n = 3,308 and 40.1%40.1% percentEstimandAge-adjusted hypertension prevalence, women 18+, Aug 2021-Aug 202395% CI37.3%–42.9% (t, df = 15)n3,308WeightWTMEC2YRVarianceTaylor linearization (design-based)SourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquetExternal benchmarkexternal benchmark: NCHS Data Brief 511 reports 40.1% (95% CI 37.2-43.1), SE 1.3, n = 3,308. The sex gap widens from 6.3 (95% CI 2.9 to 9.6)6.3 percentage pointsEstimandMen minus women, crude hypertension prevalence (percentage points), Aug 2021-Aug 202395% CI2.9 to 9.6 (t, df = 15)n6,084WeightWTMEC2YRVarianceTaylor linearization (design-based)SourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquet to 8.7 (95% CI 5.8 to 11.5)8.7 percentage pointsEstimandMen minus women, age-adjusted hypertension prevalence (percentage points), Aug 2021-Aug 202395% CI5.8 to 11.5 (t, df = 15)n6,084WeightWTMEC2YRVarianceTaylor linearization (design-based)SourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquet percentage points, because the crude comparison sets an older female population against a younger male one. Neither number is "the" prevalence. The crude share describes the actual population; the adjusted share describes a hypothetical one with the standard's age distribution, which is what makes groups and periods comparable. The pre-pandemic values, 48.1%48.1% percentEstimandPrevalence, all adults, 2017-March 202095% CI45.4%–50.7% (t, df = 25)n7,948WeightWTMECPRPVarianceTaylor linearization (design-based)SourceNHANES 2017-March 2020 pre-pandemic (P_ files); nhanes_analysis.parquet + nhanes_full_1999_2023.parquet (BPQ040A/BPQ050A) and 45.1%45.1% percentEstimandAge-adjusted hypertension prevalence, adults 18+, 2017-March 202095% CI42.6%–47.5% (t, df = 25)n7,948WeightWTMECPRPVarianceTaylor linearization (design-based)SourceNHANES 2017-March 2020 pre-pandemic (P_ files); nhanes_analysis.parquet + nhanes_full_1999_2023.parquet (BPQ040A/BPQ050A), show the same wedge.

Survey weights and standardization weights answer different questions

Hypertension prevalence, crude and age-adjusted to the 2000 U.S. standard population, 95% intervals

AUG 2021–AUG 2023All adults, crude: 47.7% (95% CI 45.4%–49.9%), n = 6,084All adults, crudeAll adults, age-adjusted: 44.5% (95% CI 42.1%–46.9%), n = 6,084All adults, age-adjustedMen, crude: 50.8% (95% CI 48.5%–53.2%), n = 2,776Men, crudeMen, age-adjusted: 48.8% (95% CI 46.1%–51.4%), n = 2,776Men, age-adjustedWomen, crude: 44.6% (95% CI 41.4%–47.7%), n = 3,308Women, crudeWomen, age-adjusted: 40.1% (95% CI 37.3%–42.9%), n = 3,308Women, age-adjusted2017–MAR 2020All adults, crude: 48.1% (95% CI 45.4%–50.7%), n = 7,948All adults, crudeAll adults, age-adjusted: 45.1% (95% CI 42.6%–47.5%), n = 7,948All adults, age-adjustedPercent of adultsAUG 2021–AUG 2023All adults, crude: 47.7% (95% CI 45.4%–49.9%), n = 6,084All adults, crudeAll adults, age-adjusted: 44.5% (95% CI 42.1%–46.9%), n = 6,084All adults, age-adjustedMen, crude: 50.8% (95% CI 48.5%–53.2%), n = 2,776Men, crudeMen, age-adjusted: 48.8% (95% CI 46.1%–51.4%), n = 2,776Men, age-adjustedWomen, crude: 44.6% (95% CI 41.4%–47.7%), n = 3,308Women, crudeWomen, age-adjusted: 40.1% (95% CI 37.3%–42.9%), n = 3,308Women, age-adjusted2017–MAR 2020All adults, crude: 48.1% (95% CI 45.4%–50.7%), n = 7,948All adults, crudeAll adults, age-adjusted: 45.1% (95% CI 42.6%–47.5%), n = 7,948All adults, age-adjustedPercent of adults
Show data
GroupEstimate forEstimate95% CIn
Aug 2021–Aug 2023All adults, crude47.7%45.4%–49.9%6,084
Aug 2021–Aug 2023All adults, age-adjusted44.5%42.1%–46.9%6,084
Aug 2021–Aug 2023Men, crude50.8%48.5%–53.2%2,776
Aug 2021–Aug 2023Men, age-adjusted48.8%46.1%–51.4%2,776
Aug 2021–Aug 2023Women, crude44.6%41.4%–47.7%3,308
Aug 2021–Aug 2023Women, age-adjusted40.1%37.3%–42.9%3,308
2017–Mar 2020All adults, crude48.1%45.4%–50.7%7,948
2017–Mar 2020All adults, age-adjusted45.1%42.6%–47.5%7,948
Figure 3.6.Age adjustment lowers prevalence and widens the gap between men and women: standardization changes the comparison population, not the representation of the sample.Note: Standardization weights s_a = 0.4203 (18–39), 0.3572 (40–59), 0.2225 (60+).Source: NHANES; 2000 U.S. standard population (Census P25-1130); chapter calculations

Domains: subset the design, not the data

Awareness, treatment, and control are domain estimates. They describe adults with hypertension, a subgroup whose sample size is itself random. The textbook rule is to declare the design on the full sample and then restrict the estimate, never to delete rows first. What the rule buys is easiest to see in the National Health Interview Survey (NHIS) 2023 (Blewett et al. 2025), which has many more PSUs: 662662EstimandNHIS 2023 PSUs, (STRATA, PSU) composite keyVarianceNone reportedSourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet) PSUs in 5252EstimandNHIS 2023 variance strataVarianceNone reportedSourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet) strata and 610610EstimandNHIS 2023 design df (#PSU - #strata)VarianceNone reportedSourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet) design degrees of freedom.The NHIS analysis uses the sample-adult weight SAMPWEIGHT and a (STRATA, PSU) key built within the year, because PSU numbers repeat across strata. For self-reported hypertension, 32.3% (95% CI 31.6%–32.9%)32.3% percentEstimandShare of 2023 sample adults ever told they had hypertension (HYPERTENEV)95% CI31.6%–32.9% (t, df = 610)n29,471WeightSAMPWEIGHTVarianceTaylor linearization (design-based)SourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet)External benchmarkprior in-house verification: 32.26%, DEFF 1.64, df 610 of 29,47129,471Estimand2023 sample adults with a valid hypertension responsen29,471VarianceNone reportedSourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet) sample adults, the design effect is 1.641.64EstimandDesign effect, ever-told hypertension, NHIS 2023 sample adultsWeightSAMPWEIGHTVarianceTaylor linearization (design-based)SourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet).

Start with the defensible-looking mistake: filter to the domain, then declare the design on what remains. For a dense domain, cost-related delay in medical care among adults with hypertension (6.4% (95% CI 5.8%–7.0%)6.4% percentEstimandShare who delayed medical care because of cost in the past 12 months, among 2023 sample adults ever told they had hypertension95% CI5.8%–7.0% (t, df = 603)n11,019WeightSAMPWEIGHTVarianceTaylor linearization (design-based)SourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet)Notedomain estimated on the full declared design; df counts PSUs and strata containing domain members (NCHS convention) of 11,01911,019EstimandUnweighted n, delayed care among adults with hypertensionn11,019VarianceNone reportedSourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet) adults), the delete-rows-first standard error is only 0.05%0.05%EstimandHow much smaller the delete-rows-first SE is than the declared-design SE, dense domainVarianceNone reportedSourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet) smaller than the correct one. For a sparse domain, uninsured adults in poor health with 4343EstimandUnweighted n, uninsured adults in poor health with a valid delayed-care responsen43VarianceNone reportedSourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet)NoteShown only to study its standard error; the proportion itself would fail NCHS presentation standards (effective n below 30) respondents, the correct standard error of the same share is 9.469.46 percentage pointsEstimandSE of the delayed-care proportion in the sparse domain, declared design (all 662 PSUs kept), percentage pointsn43WeightSAMPWEIGHTVarianceTaylor linearization (design-based)SourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet) percentage points and the delete-rows-first one is 8.268.26 percentage pointsEstimandSE of the delayed-care proportion in the sparse domain, rows deleted first, single-PSU strata as certainty units, percentage pointsn43WeightSAMPWEIGHTVarianceTaylor linearization (design-based)SourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet), which is 12.7%12.7%EstimandShortfall of the delete-rows-first SE (certainty rule) relative to the declared-design SE, proportionVarianceNone reportedSourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet) too small. For the weighted count of adults who delayed care, the shortfall is 44%44%EstimandShortfall of the delete-rows-first SE (certainty rule) for the weighted count of adults who delayed care, sparse domainVarianceNone reportedSourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet).The sparse proportion, with an effective sample size of 2828EstimandEffective sample size n / DEFF, sparse domainVarianceNone reportedSourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet), would fail the NCHS presentation standards (Parker et al. 2017); it appears here only for its standard error.

The mechanism is collapsed strata, not subsetting as such. The domain's members sit in 4141EstimandNHIS 2023 sparse domain: PSUs containing sparse-domain membersVarianceNone reportedSourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet) PSUs spread over 3030EstimandNHIS 2023 sparse domain: strata containing sparse-domain membersVarianceNone reportedSourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet) strata. Once the other rows are gone, 2222EstimandNHIS 2023 sparse domain: strata left with a single PSU after deleting rowsVarianceNone reportedSourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet) of those strata contain a single PSU, and the within-stratum comparison has nothing to compare. Declared on the full design, the same strata keep all their PSUs. PSUs with no domain members contribute totals of zero, which is how the formula learns that the domain's size varies from sample to sample, the source of variation that matters most for totals.

One sparse domain, four answers

Table comparing standard errors for delayed care among uninsured adults in poor health: the declared-design SE versus three delete-rows-first SEs under certainty, adjust and average lonely-PSU rules, for the proportion and for the weighted count.
ApproachA single-PSU stratumSE, proportion (pp)RatioSE, weighted countRatio
Declare the design, then estimate the domainnot applicable: all 662 PSUs kept9.461.00×60,4911.00×
Delete rows first; certainty or removecontributes zero8.260.87×33,7760.56×
Delete rows first; adjustdeviation from the grand mean10.461.11×46,5750.77×
Delete rows first; averageaverage of the other strata15.991.69×65,4061.08×
Figure 3.7.In a sparse domain, deleting rows first makes the standard error too small or too large, depending on a rule the analyst may never have chosen.Note: Domain: uninsured sample adults in poor self-rated health with a valid delayed-care response (n = 43). After deleting rows, 22 of 30 surviving strata have one PSU. R's default rule (fail) and svy's default both refuse to compute.Source: IPUMS NHIS 2023 sample adults; chapter calculations; checked against svy 0.28 and R survey 4.5

The software has to be told what a lonely PSU contributes, and each answer is a modeling decision (Figure 3.7). Under certainty or remove, it contributes zero, as if that PSU had been selected with certainty. Under adjust, it is centered at the grand mean rather than at its stratum mean. Under average, the other strata's variance is scaled up to stand in for it. For the sparse domain these rules give 8.268.26 percentage pointsEstimandSE of the delayed-care proportion in the sparse domain, rows deleted first, single-PSU strata as certainty units, percentage pointsn43WeightSAMPWEIGHTVarianceTaylor linearization (design-based)SourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet), 10.4610.46 percentage pointsEstimandSE of the delayed-care proportion in the sparse domain, rows deleted first, single-PSU strata centred at the grand mean, percentage pointsn43WeightSAMPWEIGHTVarianceTaylor linearization (design-based)SourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet), and 15.9915.99 percentage pointsEstimandSE of the delayed-care proportion in the sparse domain, rows deleted first, single-PSU strata given the average contribution, percentage pointsn43WeightSAMPWEIGHTVarianceTaylor linearization (design-based)SourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet) percentage points, against the correct 9.469.46 percentage pointsEstimandSE of the delayed-care proportion in the sparse domain, declared design (all 662 PSUs kept), percentage pointsn43WeightSAMPWEIGHTVarianceTaylor linearization (design-based)SourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet). R's default, survey.lonely.psu = "fail", stops with an error, and svy raises SingletonError. Both defaults force the decision into the open.

How sparse is too sparse? A controlled experiment gives a gradual answer, not a threshold (Figure 3.8). Draw 200 random domains of each size from the sample adults and compare the two standard errors for self-reported hypertension. Down to domains of about one percent of the sample, the median ratio of the delete-rows-first standard error to the correct one stays within a percent of one (0.9940.994EstimandMedian SE ratio over 200 random 1% domainsVarianceSimulationSourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet)). At 5959EstimandDomain size when 0.2% of sample adults are keptVarianceNone reportedSourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet) respondents, a median of 1919EstimandMedian number of single-PSU strata, 0.2% domainsVarianceSimulationSourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet) strata are left with one PSU, the median ratio falls to 0.810.81EstimandMedian SE ratio (delete-rows-first / declared design) over 200 random 0.2% domainsVarianceSimulationSourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet), and 80%80%EstimandShare of 200 random 0.2% domains whose delete-rows-first SE is more than 10% too smallVarianceSimulationSourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet) of the domains get a standard error more than 10 percent too small.

Thinning one domain: the understatement grows as strata collapse

Table: as a random domain of NHIS 2023 sample adults shrinks from 100% to 0.2% of the sample, PSUs with members fall from 662 to about 56, single-PSU strata rise from 0 to about 19, and the median ratio of the delete-rows-first SE to the correct SE falls from 1.00 to about 0.81.
Share of adults keptnPSUs with membersSingle-PSU stratadf after deletionSE ratio, median10th pctDraws >10% too small
100.0%29,47166206101.0001.0000%
10.0%2,94763705851.0000.9990%
2.0%58938003280.9980.9860%
1.0%29523431830.9940.9670%
0.5%14713110830.9650.9049%
0.2%595619220.8060.64180%
Figure 3.8.As the domain shrinks and strata lose PSUs, the delete-rows-first standard error drifts gradually below the correct one; the understatement becomes serious only in very small domains.Note: Each row below 100% summarizes 200 seeded random domains of fixed size (seed 20260910). SE ratio = SE after deleting non-domain rows (single-PSU strata as certainty units) / SE from the declared design. Medians shown.Source: IPUMS NHIS 2023 sample adults; outcome: ever told hypertension; chapter calculations

Two reporting rules follow. Put the PSUs retained and the number of single-PSU strata next to every domain standard error; every NHANES domain in this chapter keeps all PSUs with no lonely stratum. And state the degrees of freedom separately from the variance: NCHS counts only the PSUs and strata that contain domain members, and R and svy report the same count, 1111EstimandNHIS 2023 sparse domain: df after deleting rows (#PSU - #strata among survivors)VarianceNone reportedSourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet) for the sparse domain, although the full design has 610610EstimandNHIS 2023 design df (#PSU - #strata)VarianceNone reportedSourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet).

Analysis Ledger

A sparse domain, estimated two ways (NHIS 2023)

Target population
U.S. civilian noninstitutionalized adults 18+ without health insurance and in poor self-rated health, 2023
Estimand
Share (and number) who delayed medical care because of cost in the past 12 months
Estimator
Weighted ratio mean and weighted total within the domain
Explicit weights
SAMPWEIGHT, the sample-adult weight
Implicit weights
None
Source of randomness
Selection of PSUs within 52 strata and of households and adults within PSUs; domain membership is itself random
Variance estimator
Taylor linearization on the full declared design, (STRATA, PSU) composite key (662 PSUs); contrasted with deleting non-domain rows first under certainty, adjust, and average lonely-PSU rules
Assumptions
With-replacement PSU approximation; the domain proportion is shown only to study its standard error (effective n below 30 fails NCHS presentation standards)
Numbers reported
  • 9.469.46 percentage pointsEstimandSE of the delayed-care proportion in the sparse domain, declared design (all 662 PSUs kept), percentage pointsn43WeightSAMPWEIGHTVarianceTaylor linearization (design-based)SourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet)percentage points
  • 8.268.26 percentage pointsEstimandSE of the delayed-care proportion in the sparse domain, rows deleted first, single-PSU strata as certainty units, percentage pointsn43WeightSAMPWEIGHTVarianceTaylor linearization (design-based)SourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet)percentage points
  • 12.7%12.7%EstimandShortfall of the delete-rows-first SE (certainty rule) relative to the declared-design SE, proportionVarianceNone reportedSourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet)
  • 44%44%EstimandShortfall of the delete-rows-first SE (certainty rule) for the weighted count of adults who delayed care, sparse domainVarianceNone reportedSourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet)

Two groups in one sample

Most published comparisons are not between two surveys. They are between two groups in one: the South against the Northeast, women against men, citizens against noncitizens. Each group is a domain, and the difference between two domain means is the estimate that carries the argument. Its standard error has to be computed under the design, and it has a term the naive formula never contains: the covariance between the two estimates, which is not zero when the two groups were interviewed in the same PSUs.

Predict first

Take the uninsured share among NHIS adults 18–64 and compare it between the Northeast and the Midwest, and then between men and women. For which comparison does the design inflate the naive standard error more? And for which does it matter that the two estimates come from the same PSUs?

The family is fixed before any result is seen: the uninsured share among sample adults 18–64, the Medicaid-relevant age range that Lab 3 ranks by state, compared between every pair of groups along six dimensions, region, race and Hispanic origin, education, citizenship, sex, and age group, 2727EstimandNumber of pre-specified pairwise group comparisons of the uninsured share among adults 18-64 (region 6, race/Hispanic origin 10, education 6, citizenship 1, sex 1, age group 3)VarianceNone reportedSourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet) comparisons in all. Nationally the share is 10.8% (95% CI 10.1%–11.5%)10.8% percentEstimandShare without health insurance coverage at interview (HINOTCOVE), sample adults 18-64 with a known coverage status, NHIS 202395% CI10.1%–11.5% (t, df = 607)n19,710WeightSAMPWEIGHTVarianceTaylor linearization (design-based)SourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet)Notedomain of the full 2023 sample-adult design; df counts PSUs and strata with domain members. Most of the 2727EstimandNumber of pre-specified pairwise group comparisons of the uninsured share among adults 18-64 (region 6, race/Hispanic origin 10, education 6, citizenship 1, sex 1, age group 3)VarianceNone reportedSourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet) differences are large, and every method agrees on them: naive tests flag 2626EstimandNumber of the 27 group comparisons with p < 0.05 under naive iid (independent simple random samples)VarianceNone reportedSourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet), weights-only tests 2626EstimandNumber of the 27 group comparisons with p < 0.05 under weights-onlyVarianceNone reportedSourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet), full-design tests 2525EstimandNumber of the 27 group comparisons with p < 0.05 under full-design Taylor with the covariance (t, domain df)VarianceNone reportedSourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet), and the verdict changes for 11EstimandNumber of the 27 group comparisons whose 5 percent verdict differs between the naive and the full-design testVarianceNone reportedSourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet) (Figure 3.9). That one is the comparison a regional story would be built on. The uninsured share is 6.3%6.3%EstimandUninsured share, Northeast, adults 18-64, NHIS 2023n3,035WeightSAMPWEIGHTVarianceTaylor linearization (design-based)SourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet) in the Northeast and 8.1%8.1%EstimandUninsured share, Midwest, adults 18-64, NHIS 2023n4,157WeightSAMPWEIGHTVarianceTaylor linearization (design-based)SourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet) in the Midwest, a difference of −1.8 (95% CI −3.7 to 0.0)−1.8 percentage pointsEstimandUninsured share, Northeast minus Midwest, adults 18-64, NHIS 2023 (percentage points)95% CI−3.7 to 0.0 (t, df = 240)n7,192WeightSAMPWEIGHTVarianceTaylor linearization (design-based)SourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet)Notenaive p = 0.003; weights-only p = 0.014; design p = 0.055 percentage points. Its naive standard error is 0.610.61 percentage pointsEstimandStandard error of the Northeast minus Midwest difference, naive iid, percentage pointsWeightSAMPWEIGHTVarianceNone reportedSourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet) points (p = 0.0030.003EstimandTwo-sided naive p-value, Northeast minus Midwest uninsured shareVarianceNone reportedSourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet)), the weights-only standard error is 0.740.74 percentage pointsEstimandStandard error of the Northeast minus Midwest difference, weights-only, percentage pointsWeightSAMPWEIGHTVarianceWeights only: computed without the survey design, so not a design-based standard errorSourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet) (p = 0.0140.014EstimandTwo-sided wonly p-value, Northeast minus Midwest uninsured shareVarianceNone reportedSourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet)), and the full-design standard error is 0.940.94 percentage pointsEstimandStandard error of the Northeast minus Midwest difference, full design, percentage pointsWeightSAMPWEIGHTVarianceTaylor linearization (design-based)SourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet) (p = 0.0550.055EstimandTwo-sided design p-value, Northeast minus Midwest uninsured shareVarianceNone reportedSourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet)). The opening's two p-values were of this kind.

One sample, 27 group comparisons of the uninsured share

Table of 27 pairwise comparisons of the uninsured share among adults 18 to 64 in NHIS 2023 across region, race and Hispanic origin, education, citizenship, sex, and age group, with naive and full-design p-values; the region comparisons show the largest inflation of the standard error and the Northeast-Midwest comparison changes verdict.
DimensionGroup AGroup BABA − B (pp)SE ratio, design ÷ naiveCovariance ratiop, naivep, full design
Census regionNortheastMidwest6.3%8.1%−1.81.54×1.00×0.0030.055
Census regionNortheastSouth6.3%14.8%−8.61.65×1.00×0.0000.000
Census regionNortheastWest6.3%9.8%−3.61.47×1.00×0.0000.000
Census regionMidwestSouth8.1%14.8%−6.81.54×1.00×0.0000.000
Census regionMidwestWest8.1%9.8%−1.81.33×1.00×0.0030.027
Census regionSouthWest14.8%9.8%5.01.46×1.00×0.0000.000
Race and Hispanic originWhite NHBlack NH6.8%10.2%−3.41.26×1.00×0.0000.000
Race and Hispanic originWhite NHHispanic6.8%24.7%−17.91.42×0.98×0.0000.000
Race and Hispanic originWhite NHAsian/PI NH6.8%4.2%2.61.18×1.01×0.0000.000
Race and Hispanic originWhite NHOther/Multiple NH6.8%14.4%−7.61.22×0.99×0.0000.000
Race and Hispanic originBlack NHHispanic10.2%24.7%−14.51.36×0.99×0.0000.000
Race and Hispanic originBlack NHAsian/PI NH10.2%4.2%6.01.21×1.00×0.0000.000
Race and Hispanic originBlack NHOther/Multiple NH10.2%14.4%−4.21.23×0.99×0.0080.032
Race and Hispanic originHispanicAsian/PI NH24.7%4.2%20.51.31×0.96×0.0000.000
Race and Hispanic originHispanicOther/Multiple NH24.7%14.4%10.31.26×0.98×0.0000.000
Race and Hispanic originAsian/PI NHOther/Multiple NH4.2%14.4%−10.21.22×0.99×0.0000.000
EducationLess than HSHS28.3%14.7%13.61.25×0.97×0.0000.000
EducationLess than HSSome college28.3%8.7%19.61.24×0.96×0.0000.000
EducationLess than HSBA+28.3%4.3%24.01.27×0.98×0.0000.000
EducationHSSome college14.7%8.7%6.01.18×0.95×0.0000.000
EducationHSBA+14.7%4.3%10.41.22×0.99×0.0000.000
EducationSome collegeBA+8.7%4.3%4.41.15×0.95×0.0000.000
CitizenshipNot a citizenCitizen37.0%7.6%29.31.38×0.98×0.0000.000
SexMenWomen12.5%9.1%3.41.22×0.87×0.0000.000
Age group18-2930-4412.7%12.3%0.31.15×0.91×0.6170.664
Age group18-2945-6412.7%8.3%4.31.12×0.92×0.0000.000
Age group30-4445-6412.3%8.3%4.01.21×0.89×0.0000.000
Figure 3.9.Region comparisons carry the largest design inflation because regions are built from whole PSUs; comparisons between groups that share PSUs have a covariance the independence formula misses. One of 27 verdicts changes.Note: Uninsured at interview (HINOTCOVE). Naive: independent simple random samples, normal reference. Full design: Taylor variance of the difference on the declared (STRATA, PSU) design, covariance included, t reference with the df of PSUs and strata containing either group. Covariance ratio = design SE of the difference ÷ the design SE that treats the two groups as independent. Highlighted rows change verdict at the 5 percent level. No adjustment for multiple comparisons.Source: IPUMS NHIS 2023 sample adults 18–64; chapter calculations

Two patterns in Figure 3.9 answer the prediction. First, geography is where clustering bites hardest. A region is a union of whole PSUs, so a comparison between regions is a comparison between two sets of counties, and every PSU's shared conditions land entirely on one side of it. Over the six region comparisons the full-design standard error is a median 1.501.50EstimandMedian ratio of the full-design to the naive SE of the difference over the 6 region comparisonsVarianceNone reportedSourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet) times the naive one; over the other 21 it is 1.221.22EstimandMedian ratio of the full-design to the naive SE of the difference over the 21 non-geographic comparisonsVarianceNone reportedSourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet) times. Second, the covariance runs the other way. Two regions share no PSU, and the design standard error of their difference equals the value the independence formula SEa2+SEb2\sqrt{\SE_a^2 + \SE_b^2} gives (median ratio 1.001.00EstimandMedian covariance ratio (design SE with covariance / design SE assuming independence) over the 6 region comparisonsVarianceNone reportedSourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet)). Men and women live in the same households and the same counties, their estimates move together across repeated samples, and the design standard error of their difference is 0.870.87EstimandSmallest ratio of the design SE with the covariance to the design SE assuming the two domains independent, over the 27 comparisons (Men vs Women)VarianceNone reportedSourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet) times the independence value: the positive covariance makes the comparison more precise, not less. Overlapping confidence intervals are therefore not a test in either direction. Even for independent estimates the standard error of a difference is 2\sqrt{2} times one of them and not twice, so two intervals can overlap while the interval for the difference excludes zero, and shared PSUs change the answer again. Estimate the difference itself, on the declared design, with both groups kept in the frame.

Analysis Ledger

Which groups of adults differ in coverage? (NHIS 2023)

Target population
U.S. civilian noninstitutionalized adults 18–64 in 2023, by Census region, race and Hispanic origin, education, citizenship, sex, and age group
Estimand
Differences between pairs of groups in the finite-population share without health insurance at interview; 27 pre-specified comparisons
Estimator
Difference of two weighted ratio (Hájek) means, each a domain of the full sample-adult design
Explicit weights
SAMPWEIGHT, the sample-adult weight
Implicit weights
None
Source of randomness
One stratified multistage sample; both groups in every comparison come from the same PSUs, so their estimates covary
Variance estimator
Taylor linearization of the difference on the declared design, (STRATA, PSU) composite key, covariance included; t with the df of PSUs and strata containing either group; compared with naive iid and weights-only variances
Assumptions
With-replacement PSU approximation; item nonresponse on coverage excluded; no multiplicity adjustment; descriptive contrasts, not effects
Numbers reported
  • 10.8%10.8% percentEstimandShare without health insurance coverage at interview (HINOTCOVE), sample adults 18-64 with a known coverage status, NHIS 202395% CI10.1%–11.5% (t, df = 607)n19,710WeightSAMPWEIGHTVarianceTaylor linearization (design-based)SourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet)Notedomain of the full 2023 sample-adult design; df counts PSUs and strata with domain memberspercent
  • 2727EstimandNumber of pre-specified pairwise group comparisons of the uninsured share among adults 18-64 (region 6, race/Hispanic origin 10, education 6, citizenship 1, sex 1, age group 3)VarianceNone reportedSourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet)
  • 2626EstimandNumber of the 27 group comparisons with p < 0.05 under naive iid (independent simple random samples)VarianceNone reportedSourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet)
  • 2525EstimandNumber of the 27 group comparisons with p < 0.05 under full-design Taylor with the covariance (t, domain df)VarianceNone reportedSourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet)
  • −1.8−1.8 percentage pointsEstimandUninsured share, Northeast minus Midwest, adults 18-64, NHIS 2023 (percentage points)95% CI−3.7 to 0.0 (t, df = 240)n7,192WeightSAMPWEIGHTVarianceTaylor linearization (design-based)SourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet)Notenaive p = 0.003; weights-only p = 0.014; design p = 0.055percentage points

Two complex surveys, opposite uncertainty

"Complex survey" names a family, not a property. The Behavioral Risk Factor Surveillance System (BRFSS) 2024 (CDC 2024) interviewed 457,670457,670EstimandRespondents in the BRFSS 2024 public fileVarianceNone reportedSourceCDC BRFSS 2024 public file (BRFSS_2026/cleaned/brfss_multi_rec.parquet); 49 states (no Tennessee), DC, Guam, Puerto Rico, U.S. Virgin Islands adults by telephone in 2,3932,393EstimandBRFSS 2024 strata (_STSTR)VarianceNone reportedSourceCDC BRFSS 2024 public file (BRFSS_2026/cleaned/brfss_multi_rec.parquet); 49 states (no Tennessee), DC, Guam, Puerto Rico, U.S. Virgin Islands strata, and each respondent is a PSU: 457,670457,670EstimandBRFSS 2024 PSUs, (_STSTR, _PSU) composite key; one respondent per PSUVarianceNone reportedSourceCDC BRFSS 2024 public file (BRFSS_2026/cleaned/brfss_multi_rec.parquet); 49 states (no Tennessee), DC, Guam, Puerto Rico, U.S. Virgin Islands PSUs and 455,277455,277EstimandBRFSS 2024 design df (#PSU - #strata)VarianceNone reportedSourceCDC BRFSS 2024 public file (BRFSS_2026/cleaned/brfss_multi_rec.parquet); 49 states (no Tennessee), DC, Guam, Puerto Rico, U.S. Virgin Islands design degrees of freedom. Its raked weights (Chapter 2) vary widely, with a coefficient of variation of 2.032.03EstimandCoefficient of variation of _LLCPWT among respondents with a valid general-health answer, BRFSS 2024VarianceNone reportedSourceCDC BRFSS 2024 public file (BRFSS_2026/cleaned/brfss_multi_rec.parquet); 49 states (no Tennessee), DC, Guam, Puerto Rico, U.S. Virgin Islands. For fair or poor self-rated health, 19.6% (95% CI 19.3%–19.8%)19.6% percentEstimandShare of adults reporting fair or poor general health (CDC _RFHLTH), BRFSS 2024 participating jurisdictions95% CI19.3%–19.8% (t, df = 453967)n456,360Weight_LLCPWTVarianceTaylor linearization (design-based)SourceCDC BRFSS 2024 public file (BRFSS_2026/cleaned/brfss_multi_rec.parquet); 49 states (no Tennessee), DC, Guam, Puerto Rico, U.S. Virgin IslandsNotelonely-PSU rule: adjust; 110 single-respondent strata in the full design, the design effect is 5.245.24EstimandDesign effect, fair or poor self-rated health, BRFSS 2024Weight_LLCPWTVarianceTaylor linearization (design-based)SourceCDC BRFSS 2024 public file (BRFSS_2026/cleaned/brfss_multi_rec.parquet); 49 states (no Tennessee), DC, Guam, Puerto Rico, U.S. Virgin Islands: a weighting factor of 5.265.26EstimandWeighting factor, fair or poor health, BRFSS 2024VarianceNone reportedSourceCDC BRFSS 2024 public file (BRFSS_2026/cleaned/brfss_multi_rec.parquet); 49 states (no Tennessee), DC, Guam, Puerto Rico, U.S. Virgin Islands times a clustering-and-stratification factor of 1.001.00EstimandClustering-and-stratification factor, fair or poor health, BRFSS 2024VarianceNone reportedSourceCDC BRFSS 2024 public file (BRFSS_2026/cleaned/brfss_multi_rec.parquet); 49 states (no Tennessee), DC, Guam, Puerto Rico, U.S. Virgin Islands. NHANES is the mirror image, with a weighting factor of 1.511.51EstimandWeighting factor: (weights-only SE / naive SE) squared, crude prevalence, Aug 2021-Aug 2023WeightWTMEC2YRVarianceNone reportedSourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquet, a clustering factor of 1.801.80EstimandClustering-and-stratification factor: (design SE / weights-only SE) squared, crude prevalence, Aug 2021-Aug 2023WeightWTMEC2YRVarianceNone reportedSourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquet, and 1515EstimandDesign degrees of freedom (#PSU - #strata), Aug 2021-Aug 2023VarianceNone reportedSourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquet degrees of freedom. NHIS sits between them (Figure 3.10).

The contrast changes what the analyst should worry about. In BRFSS the t critical value is 1.961.96Estimand97.5th percentile of the standard normalVarianceNone reportedSourcescipy.stats.norm and the degrees of freedom never bind, but unequal weights use up most of the sample's information. In NHANES the weights cost less, and a handful of PSUs determines both the variance and how precisely the variance itself is estimated. Even BRFSS needs a lonely-PSU rule: 110110EstimandBRFSS 2024 strata containing a single respondentVarianceNone reportedSourceCDC BRFSS 2024 public file (BRFSS_2026/cleaned/brfss_multi_rec.parquet); 49 states (no Tennessee), DC, Guam, Puerto Rico, U.S. Virgin Islands of its strata contain a single respondent, and this chapter uses adjust.BRFSS 2024 omits Tennessee, so its target population is adults in the participating jurisdictions.

Complex surveys, opposite sources of uncertainty

Table comparing NHANES, NHIS and BRFSS: NHANES has 30 PSUs and 15 design degrees of freedom and its design effect comes mostly from clustering; BRFSS has one respondent per PSU and about 455,000 degrees of freedom and its design effect comes almost entirely from unequal weights.
SurveyExample estimandAnalytic nStrataPSUsDesign dft(0.975)1 + CV(w)²Weighting factorClustering × strata factorDEFF
NHANES Aug 2021–Aug 2023Hypertension, measured or medicated6,0841530152.131.52×1.51×1.80×2.72×
NHIS 2023 sample adultsEver told hypertension29,471526626101.961.42×1.30×1.26×1.64×
BRFSS 2024Fair or poor general health456,3602,393457,670455,2771.965.13×5.26×1.00×5.24×
Figure 3.10.NHANES uncertainty comes from few PSUs and BRFSS uncertainty from unequal weights; both surveys are called complex.Note: DEFF = weighting factor × clustering-and-stratification factor, by construction: (weights-only SE / naive SE)² × (design SE / weights-only SE)². BRFSS 2024 omits Tennessee; its Taylor SE uses the adjust rule for 110 single-respondent strata.Source: NHANES August 2021–August 2023; IPUMS NHIS 2023; CDC BRFSS 2024; chapter calculations

Interlude: weighting repairs representation, not measurement

Weights can correct for who answered. They cannot correct what was measured. Three surveys ask adults whether a health professional ever told them they had high blood pressure: BRFSS 2023 gives 34.4% (95% CI 34.0%–34.7%)34.4% percentEstimandShare of adults 18+ ever told they have high blood pressure (CDC _RFHYPE6 coding of BPHIGH6: 1 = yes; 2, 3, 4 = no), 48 states and DC, BRFSS 202395% CI34.0%–34.7% (t, df = 421070)n423,197Weight_LLCPWTVarianceTaylor linearization (design-based)SourceCDC BRFSS 2023 public file (BRFSS_2026/cleaned/brfss_multi_rec.parquet); 48 states (no Kentucky, no Pennsylvania) and DCNotelonely-PSU rule: adjust (centre single-PSU strata at the grand mean); territories excluded as a domain, NHIS 2023 gives 32.3%32.3% percentEstimandShare of 2023 sample adults ever told they had hypertension (HYPERTENEV)95% CI31.6%–32.9% (t, df = 610)n29,471WeightSAMPWEIGHTVarianceTaylor linearization (design-based)SourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet)External benchmarkprior in-house verification: 32.26%, DEFF 1.64, df 610, and NHANES's own interview gives 30.8%30.8% percentEstimandShare of adults 18+ (not pregnant) ever told by a health professional they had hypertension (self-report, BPQ020), NHANES Aug 2021-Aug 2023 MEC sample95% CI28.6%–32.9% (t, df = 15)n6,080WeightWTMEC2YRVarianceTaylor linearization (design-based)SourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquet. NHANES's measured definition gives 47.7%47.7% percentEstimandCrude prevalence of hypertension among U.S. civilian noninstitutionalized adults 18+ (pregnant women excluded), Aug 2021-Aug 202395% CI45.4%–49.9% (t, df = 15)n6,084WeightWTMEC2YRVarianceTaylor linearization (design-based)SourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquetExternal benchmarkexternal benchmark: NCHS Data Brief 511 reports 47.7% (95% CI 45.4-49.9), SE 1.1, n = 6,084, and the older 140/90 threshold applied to the same readings gives 32.4%32.4% percentEstimandHypertension defined as SBP >= 140 or DBP >= 90 or medication (the pre-2017 threshold), adults 18+, Aug 2021-Aug 202395% CI29.9%–34.9% (t, df = 15)n6,084WeightWTMEC2YRVarianceTaylor linearization (design-based)SourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquet (Figure 3.11). The gap between self-report and measurement is not a representation error that better weights could close. The surveys estimate different constructs: a remembered diagnosis on one side, a blood pressure reading plus medication use on the other.BRFSS asks this item only in odd years, and 2023 omits Kentucky and Pennsylvania, so its population is adults in 48 states and the District of Columbia.

Three surveys, two constructs

Adults 18+, share with high blood pressure, 95% full-design intervals

SELF-REPORTED DIAGNOSISBRFSS 2023: told high blood pressure: 34.4% (95% CI 34.0%–34.7%), n = 423,197BRFSS 2023: told high blood pressureNHIS 2023: told hypertension: 32.3% (95% CI 31.6%–32.9%), n = 29,471NHIS 2023: told hypertensionNHANES 2021–23: told high blood pressure: 30.8% (95% CI 28.6%–32.9%), n = 6,080NHANES 2021–23: told high blood pre…MEASUREDNHANES 2021–23: measured ≥140/90 or medication: 32.4% (95% CI 29.9%–34.9%), n = 6,084NHANES 2021–23: measured ≥140/90…NHANES 2021–23: measured ≥130/80 or medication: 47.7% (95% CI 45.4%–49.9%), n = 6,084NHANES 2021–23: measured ≥130/80…Percent of adultsSELF-REPORTED DIAGNOSISBRFSS 2023: told high blood pressure: 34.4% (95% CI 34.0%–34.7%), n = 423,197BRFSS 2023: told high blood pressureNHIS 2023: told hypertension: 32.3% (95% CI 31.6%–32.9%), n = 29,471NHIS 2023: told hypertensionNHANES 2021–23: told high blood pressure: 30.8% (95% CI 28.6%–32.9%), n = 6,080NHANES 2021–23: told high blood pressureMEASUREDNHANES 2021–23: measured ≥140/90 or medication: 32.4% (95% CI 29.9%–34.9%), n = 6,084NHANES 2021–23: measured ≥140/90 or medicationNHANES 2021–23: measured ≥130/80 or medication: 47.7% (95% CI 45.4%–49.9%), n = 6,084NHANES 2021–23: measured ≥130/80 or medicationPercent of adults
Show data
GroupEstimate forEstimate95% CIn
Self-reported diagnosisBRFSS 2023: told high blood pressure34.4%34.0%–34.7%423,197
Self-reported diagnosisNHIS 2023: told hypertension32.3%31.6%–32.9%29,471
Self-reported diagnosisNHANES 2021–23: told high blood pressure30.8%28.6%–32.9%6,080
MeasuredNHANES 2021–23: measured ≥140/90 or medication32.4%29.9%–34.9%6,084
MeasuredNHANES 2021–23: measured ≥130/80 or medication47.7%45.4%–49.9%6,084
Figure 3.11.Self-reported diagnosis agrees across three surveys; measured hypertension is a different construct, and no weighting reconciles the two.Note: BRFSS 2023 covers 48 states and DC (Kentucky and Pennsylvania did not meet data standards). Calendar periods differ slightly.Source: CDC BRFSS 2023; IPUMS NHIS 2023; NHANES August 2021–August 2023; chapter calculations

NHANES shows the same lesson inside one survey. In 2017–2018, NCHS measured the same examinees with both the old auscultatory protocol and the new oscillometric device, in random order (NCHS 2024). For those 4,6334,633EstimandAnalytic sample, examined adults 18+ (not pregnant) in 2017-2018 with valid readings from both protocolsn4,633VarianceNone reportedSourceNHANES 2017-2018 (_J files), BPXO_J and BPX_J on the same participants; nhanes_full_1999_2023.parquet adults, with identical weights, mean systolic pressure was 1.5 (95% CI 0.8 to 2.2)1.5 mm HgEstimandMean systolic BP, auscultatory minus oscillometric, same participants (mm Hg)95% CI0.8 to 2.2 (t, df = 15)n4,633WeightWTMEC2YRVarianceTaylor linearization (design-based)SourceNHANES 2017-2018 (_J files), BPXO_J and BPX_J on the same participants; nhanes_full_1999_2023.parquet mm Hg higher by auscultation, and prevalence under the 130/80-or-medication definition was 48.4%48.4% percentEstimandHypertension (>= 130/80 or medication) using auscultatory readings, examined adults 18+ (not pregnant) in 2017-2018 with valid readings from both protocols95% CI45.3%–51.5% (t, df = 15)n4,633WeightWTMEC2YRVarianceTaylor linearization (design-based)SourceNHANES 2017-2018 (_J files), BPXO_J and BPX_J on the same participants; nhanes_full_1999_2023.parquet by auscultation against 47.6%47.6% percentEstimandHypertension (>= 130/80 or medication) using oscillometric readings, examined adults 18+ (not pregnant) in 2017-2018 with valid readings from both protocols95% CI44.6%–50.7% (t, df = 15)n4,633WeightWTMEC2YRVarianceTaylor linearization (design-based)SourceNHANES 2017-2018 (_J files), BPXO_J and BPX_J on the same participants; nhanes_full_1999_2023.parquet by the device, a difference of 0.7 (95% CI −1.4 to 2.8)0.7 percentage pointsEstimandAuscultatory minus oscillometric prevalence of hypertension (>= 130/80 or medication), same participants and weight, percentage points95% CI−1.4 to 2.8 (t, df = 15)n4,633WeightWTMEC2YRVarianceTaylor linearization (design-based)SourceNHANES 2017-2018 (_J files), BPXO_J and BPX_J on the same participants; nhanes_full_1999_2023.parquet percentage points (1.11.1 percentage pointsEstimandAuscultatory minus oscillometric prevalence of measured BP >= 130/80 alone, same participants and weight, percentage points95% CI−1.6 to 3.9 (t, df = 15)n4,633WeightWTMEC2YRVarianceTaylor linearization (design-based)SourceNHANES 2017-2018 (_J files), BPXO_J and BPX_J on the same participants; nhanes_full_1999_2023.parquet points for the readings-alone definition). Representation is identical by construction; only the instrument changed. That is why the period comparison above uses two oscillometric samples.

Replicate weights, briefly

NHANES releases masked strata and PSUs, so Taylor linearization is the producer's method. Other surveys ship replicate weights instead: the American Community Survey provides 80 alternative weight columns and the CPS ASEC provides 160. Replicate weights are the survey world's pre-packaged repeated sampling: re-estimate once with each column, and the spread of the replicate estimates, scaled by a method-specific constant, approximates the sampling variance. Balanced repeated replication, Fay's method (Fay and Train 1995), the jackknife, successive difference replication, and the bootstrap are distinct procedures with different constants and degrees of freedom; calling them all "a bootstrap" hides exactly the constants an analyst must get right. Because the producer repeats the weighting steps inside each replicate, the replicate variance also carries the weight-construction variability that fixed-weight linearization leaves out. Lab 3 works through the American Community Survey case.

The tools

Every design-based number in this chapter comes from one declaration: the stratum, the PSU, and the weight. The two calls below return the same estimate, standard error, design effect, and degrees of freedom to machine precision, and the chapter's build checks both against a hand-written Taylor routine.

python
import polars as pl
import svy
 
# nh: one row per MEC-examined participant (WTMEC2YR > 0) with 0/1 columns
# htn and analytic built as defined above. PSU codes repeat across strata.
nh = nh.with_columns((pl.col("SDMVSTRA") * 10 + pl.col("SDMVPSU")).alias("psu"))
design = svy.Design(stratum="SDMVSTRA", psu="psu", wgt="WTMEC2YR")
sample = svy.Sample(nh, design=design)
prev = sample.estimation.mean("htn", where=svy.col("analytic") == 1, deff="wr")
r
des <- svydesign(ids = ~SDMVPSU, strata = ~SDMVSTRA, weights = ~WTMEC2YR,
                 nest = TRUE, data = nh)
svymean(~htn, subset(des, analytic), deff = "replace")

The domain rule is the where argument in svy and subset() on the design object in R; filtering the data frame first is the mistake from the domain section. A difference between two domains is one more line: svyby(..., covmat = TRUE) followed by svycontrast() keeps the covariance between the two group estimates, which is how the men-minus-women standard error in Figure 3.9 was checked.

python
# Wrong: delete rows, then declare. svy refuses to guess.
sub = svy.Sample(adults.filter(pl.col("sparse") == 1), design=design)
sub.estimation.mean("delay")            # raises SingletonError
sub.singleton.handle("certainty")       # an explicit rule you must report
# Right: keep every PSU and restrict the estimate.
svy.Sample(adults, design=design).estimation.mean("delay", where=svy.col("sparse") == 1)

What we learned about the question

Hypertension is common and poorly controlled. In August 2021–August 2023, 47.7%47.7% percentEstimandCrude prevalence of hypertension among U.S. civilian noninstitutionalized adults 18+ (pregnant women excluded), Aug 2021-Aug 202395% CI45.4%–49.9% (t, df = 15)n6,084WeightWTMEC2YRVarianceTaylor linearization (design-based)SourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquetExternal benchmarkexternal benchmark: NCHS Data Brief 511 reports 47.7% (95% CI 45.4-49.9), SE 1.1, n = 6,084 of adults met the 130/80-or-medication definition; of those, 59.2%59.2% percentEstimandShare told by a health professional they have hypertension, among adults 18+ with hypertension (SBP >= 130 or DBP >= 80 mm Hg, or taking BP medication), Aug 2021-Aug 202395% CI56.5%–61.9% (t, df = 15)n3,240WeightWTMEC2YRVarianceTaylor linearization (design-based)SourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquetExternal benchmarkexternal benchmark: NCHS Data Brief 511 reports 59.2% (95% CI 56.4-61.9), SE 1.3, n = 3,240 knew it, 51.2%51.2% percentEstimandShare taking prescribed BP medication, among adults 18+ with hypertension (SBP >= 130 or DBP >= 80 mm Hg, or taking BP medication), Aug 2021-Aug 202395% CI48.7%–53.7% (t, df = 15)n3,238WeightWTMEC2YRVarianceTaylor linearization (design-based)SourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquetExternal benchmarkexternal benchmark: NCHS Data Brief 511 reports 51.2% (95% CI 48.6-53.7), SE 1.2, n = 3,238 were treated, and 20.7%20.7% percentEstimandShare with SBP < 130 and DBP < 80 mm Hg, among adults 18+ with hypertension (SBP >= 130 or DBP >= 80 mm Hg, or taking BP medication), Aug 2021-Aug 202395% CI18.8%–22.7% (t, df = 15)n3,242WeightWTMEC2YRVarianceTaylor linearization (design-based)SourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquetExternal benchmarkexternal benchmark: NCHS Data Brief 511 reports 20.7% (95% CI 18.8-22.8), SE 0.9, n = 3,242 had it controlled. None of the four national shares changed detectably from 2017–March 2020. Two of the three subgroup changes that naive intervals flag do not exclude zero under the declared design, and the third is one of 24 comparisons. In the NHIS, 2525EstimandNumber of the 27 group comparisons with p < 0.05 under full-design Taylor with the covariance (t, domain df)VarianceNone reportedSourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet) of 2727EstimandNumber of pre-specified pairwise group comparisons of the uninsured share among adults 18-64 (region 6, race/Hispanic origin 10, education 6, citizenship 1, sex 1, age group 3)VarianceNone reportedSourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet) group differences in the uninsured share among adults 18–64 hold under the design; the Northeast–Midwest difference, −1.8−1.8 percentage pointsEstimandUninsured share, Northeast minus Midwest, adults 18-64, NHIS 2023 (percentage points)95% CI−3.7 to 0.0 (t, df = 240)n7,192WeightSAMPWEIGHTVarianceTaylor linearization (design-based)SourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet)Notenaive p = 0.003; weights-only p = 0.014; design p = 0.055 percentage points, does not.

What the method changed

The point estimates never changed. What changed was the width of every interval (for prevalence, 1.81.8EstimandFull-design 95% CI width (t, df 15) divided by naive 95% CI width, crude prevalenceVarianceNone reportedSourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquet times the naive width, with 1515EstimandDesign degrees of freedom (#PSU - #strata), Aug 2021-Aug 2023VarianceNone reportedSourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquet degrees of freedom), the number of subgroup changes whose intervals exclude zero (from 33EstimandNumber of the 24 period comparisons (4 cascade stages x 6 groups) with p < 0.05 under naive iid (normal)VarianceNone reportedSourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquet; NHANES 2017-March 2020 pre-pandemic (P_ files); nhanes_analysis.parquet + nhanes_full_1999_2023.parquet (BPQ040A/BPQ050A) to 11EstimandNumber of the 24 period comparisons (4 cascade stages x 6 groups) with p < 0.05 under full-design Taylor (t, Satterthwaite df)VarianceNone reportedSourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquet; NHANES 2017-March 2020 pre-pandemic (P_ files); nhanes_analysis.parquet + nhanes_full_1999_2023.parquet (BPQ040A/BPQ050A)), the standard errors of sparse domains, the standard error of a difference between two groups in one sample, which grew by a median factor of 1.501.50EstimandMedian ratio of the full-design to the naive SE of the difference over the 6 region comparisonsVarianceNone reportedSourceIPUMS NHIS 2023 sample adults (analysis/nhis/nhis_core/part_2015_2024.parquet) across regions and fell below the independence value for men against women, and, through standardization weights, the population in which men and women are compared.

What this analysis does not establish

This analysis does not show that the cascade was stable in every subgroup: the interval for the national change in control, −1.5 (95% CI −4.0 to 1.0)−1.5 percentage pointsEstimandChange in control (adults with hypertension; All adults), Aug 2021-Aug 2023 minus 2017-March 2020, percentage points95% CI−4.0 to 1.0 (t, df = 34)n7,547WeightWTMEC2YR (2021-2023) / WTMECPRP (2017-March 2020)VarianceTaylor linearization (design-based)SourceNHANES August 2021-August 2023 (_L files), MEC-examined adults; NHANES/data/processed/nhanes_analysis.parquet; NHANES 2017-March 2020 pre-pandemic (P_ files); nhanes_analysis.parquet + nhanes_full_1999_2023.parquet (BPQ040A/BPQ050A)Notenaive p = 0.126; design p = 0.244 (Satterthwaite df 34.4) percentage points, is wide enough to hide a meaningful decline, and subgroup intervals are wider still. It establishes no trend beyond two periods and nothing about why control did or did not change; the pandemic is a date here, not a cause. Treatment rests on self-reported medication use, asked differently in the two periods. Agreement with NCHS Data Brief 511 validates the code, not the population values. The NHIS group differences are descriptive contrasts, tested one at a time without a multiplicity adjustment, and the Northeast–Midwest comparison is not shown to be zero, only not distinguishable from it. The sparse NHIS proportion is not a publishable estimate, and the implied intraclass correlation is a back-of-envelope reading of an equal-cluster formula.